arsonic acid - Ontology Report - Rat Genome Database

Submit Data | Help | Video Tutorials | News | Publications | Download | REST API | Citing RGD | Contact

Advanced Search (OLGA)

CHEBI ONTOLOGY - ANNOTATIONS

{{ watchLinkText }}

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:	arsonic acid	go back to main search page
Accession:	CHEBI:29850	browse the term
Definition:	A member of the arsonic acids that has formula AsH3O3.
Synonyms:	exact_synonym:	hydridodihydroxidooxidoarsenic
	related_synonym:	Formula=AsH3O3; H2AsHO3; InChI=1S/AsH3O3/c2-1(3)4/h1H,(H2,2,3,4); InChIKey=BUSBFZWLPXDYIC-UHFFFAOYSA-N; SMILES=[H][As](O)(O)=O; [AsHO(OH)2]
	xref:	Gmelin:2037439
	cyclic_relationship:	is_conjugate_acid_of CHEBI:64448

show annotations for term's descendants Sort by:
Rat (664 ) Mouse (777 ) Human (684 ) Chinchilla (0 ) Bonobo (0 ) Dog (0 ) Squirrel (0 ) Pig (0 ) Green Monkey (0) Naked Mole-rat (0 ) All
Genes (664)

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

brain-derived neurotrophic factor

decreases expression
multiple interactions

EXP

Arsanilic Acid results in decreased expression of BDNF mRNA; Arsanilic Acid results in decreased expression of BDNF protein
Dexamethasone inhibits the reaction [Arsanilic Acid results in decreased expression of BDNF mRNA]; Dexamethasone inhibits the reaction [Arsanilic Acid results in decreased expression of BDNF protein]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [Arsanilic Acid results in decreased expression of BDNF mRNA]]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [Arsanilic Acid results in decreased expression of BDNF protein]]

NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:116,619,633...116,670,657

G

caspase 3

increases activity
increases expression
multiple interactions
increases cleavage

EXP

Arsanilic Acid results in increased activity of CASP3 protein
Arsanilic Acid results in increased expression of CASP3 mRNA
Dexamethasone inhibits the reaction [Arsanilic Acid results in increased cleavage of CASP3 protein]; Dexamethasone inhibits the reaction [Arsanilic Acid results in increased expression of CASP3 mRNA]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [Arsanilic Acid results in increased cleavage of CASP3 protein]]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [Arsanilic Acid results in increased expression of CASP3 mRNA]]

PMID:23848144 PMID:30628712

NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732

G

caspase 9

increases activity

EXP

Arsanilic Acid results in increased activity of CASP9 protein

Ensembl chr 5:159,391,188...159,409,648

G

neurotrophic receptor tyrosine kinase 2

decreases expression
multiple interactions

EXP

Arsanilic Acid results in decreased expression of NTRK2 mRNA; Arsanilic Acid results in decreased expression of NTRK2 protein
Dexamethasone inhibits the reaction [Arsanilic Acid results in decreased expression of NTRK2 mRNA]; Dexamethasone inhibits the reaction [Arsanilic Acid results in decreased expression of NTRK2 protein]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [Arsanilic Acid results in decreased expression of NTRK2 mRNA]]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [Arsanilic Acid results in decreased expression of NTRK2 protein]]

NCBI chr17:5,560,558...5,875,899
Ensembl chr17:5,564,570...5,874,628

G

solute carrier family 12 member 5

decreases expression
multiple interactions

EXP

Arsanilic Acid results in decreased expression of SLC12A5 mRNA; Arsanilic Acid results in decreased expression of SLC12A5 protein
Dexamethasone inhibits the reaction [Arsanilic Acid results in decreased expression of SLC12A5 mRNA]; Dexamethasone inhibits the reaction [Arsanilic Acid results in decreased expression of SLC12A5 protein]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [Arsanilic Acid results in decreased expression of SLC12A5 mRNA]]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [Arsanilic Acid results in decreased expression of SLC12A5 protein]]

NCBI chr 3:174,115,833...174,155,112
Ensembl chr 3:174,115,833...174,155,112

methylarsonic acid

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

alpha-2-macroglobulin-like 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of A2ML1 mRNA

NCBI chr 4:161,815,111...161,857,286
Ensembl chr 4:163,501,585...163,543,506

G

acetoacetyl-CoA synthetase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of AACS mRNA

NCBI chr12:36,774,471...36,817,835
Ensembl chr12:36,774,471...36,822,543

G

alanine and arginine rich domain containing protein

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of AARD mRNA

NCBI chr 7:83,364,478...83,369,319
Ensembl chr 7:85,253,992...85,259,163

G

ATP binding cassette subfamily B member 1A

increases expression

EXP

monomethylarsonic acid results in increased expression of ABCB1A mRNA; monomethylarsonic acid results in increased expression of ABCB1A protein

NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135

G

ATP binding cassette subfamily C member 1

increases expression
affects expression

EXP
ISO

monomethylarsonic acid results in increased expression of ABCC1 mRNA; monomethylarsonic acid results in increased expression of ABCC1 protein
monomethylarsonic acid affects the expression of ABCC1 mRNA

PMID:16436460 PMID:24091636

NCBI chr10:1,022,041...1,162,431
Ensembl chr10:1,038,947...1,162,404

G

ATP binding cassette subfamily C member 2

increases expression

EXP
ISO

monomethylarsonic acid results in increased expression of ABCC2 mRNA; monomethylarsonic acid results in increased expression of ABCC2 protein

PMID:16436460 PMID:24091636

NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:252,614,017...252,673,471

G

ATP binding cassette subfamily C member 3

increases expression

EXP

monomethylarsonic acid results in increased expression of ABCC3 mRNA; monomethylarsonic acid results in increased expression of ABCC3 protein

NCBI chr10:79,793,571...79,839,528
Ensembl chr10:79,793,583...79,839,494

G

ArfGAP with coiled-coil, ankyrin repeat and PH domains 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ACAP1 mRNA

NCBI chr10:55,104,040...55,119,280
Ensembl chr10:55,104,040...55,118,185

G

acyl-CoA thioesterase 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ACOT1 mRNA

NCBI chr 6:109,367,274...109,375,268
Ensembl chr 6:109,367,268...109,380,749

G

acyl-CoA thioesterase 12

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ACOT12 mRNA

NCBI chr 2:22,986,867...23,027,538
Ensembl chr 2:24,721,910...24,765,298

G

acyl-CoA oxidase 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ACOX2 mRNA

NCBI chr15:19,090,820...19,122,392
Ensembl chr15:19,090,926...19,122,392

G

acrosin binding protein

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ACRBP mRNA

NCBI chr 4:159,537,395...159,550,454
Ensembl chr 4:159,537,391...159,550,454

G

ADAM metallopeptidase with thrombospondin type 1 motif, 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ADAMTS4 mRNA

NCBI chr13:86,203,011...86,212,500
Ensembl chr13:86,202,642...86,212,514

G

ADAM metallopeptidase with thrombospondin type 1 motif, 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ADAMTS6 mRNA

NCBI chr 2:35,421,483...35,633,305
Ensembl chr 2:37,155,288...37,367,070

G

adhesion G protein-coupled receptor G1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ADGRG1 mRNA

NCBI chr19:10,009,983...10,047,138
Ensembl chr19:10,010,031...10,047,124

G

adrenomedullin

multiple interactions
increases expression

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ADM mRNA
monomethylarsonic acid results in increased expression of ADM mRNA

PMID:34876320 PMID:38630284

NCBI chr 1:174,164,178...174,182,372
Ensembl chr 1:174,178,773...174,182,371

G

adrenoceptor alpha 2B

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ADRA2B mRNA

NCBI chr 3:135,038,481...135,042,527
Ensembl chr 3:135,038,474...135,042,525

G

adrenoceptor beta 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ADRB1 mRNA

NCBI chr 1:265,777,103...265,780,114
Ensembl chr 1:265,766,079...265,849,237

G

adrenoceptor beta 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ADRB2 mRNA

NCBI chr18:57,912,760...57,914,802
Ensembl chr18:57,911,348...57,914,803

G

ALF transcription elongation factor 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of AFF3 mRNA

NCBI chr 9:47,894,903...48,352,380
Ensembl chr 9:47,894,903...48,353,000

G

alpha-fetoprotein

increases expression

ISO

monomethylarsonic acid results in increased expression of AFP mRNA

NCBI chr14:17,857,584...17,875,645
Ensembl chr14:17,857,584...17,875,649

G

anterior gradient 3, protein disulphide isomerase family member

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of AGR3 mRNA

NCBI chr 6:52,643,391...52,666,638
Ensembl chr 6:58,370,701...58,399,859

G

AT hook, DNA binding motif, containing 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of AHDC1 mRNA

NCBI chr 5:150,512,182...150,578,804
Ensembl chr 5:150,512,037...150,583,144

G

aryl hydrocarbon receptor

multiple interactions

ISO

AHR mutant form inhibits the reaction [monomethylarsonic acid results in increased expression of CYP1A1 protein]; monomethylarsonic acid results in decreased expression of and affects the localization of AHR protein

NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901

G

adenylate kinase 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of AK4 mRNA

NCBI chr 5:121,154,565...121,214,403
Ensembl chr 5:121,154,572...121,214,401

G

aldo-keto reductase family 1, member C3

increases expression

ISO

monomethylarsonic acid results in increased expression of AKR1C3 mRNA

NCBI chr17:71,020,884...71,037,779
Ensembl chr17:70,970,900...71,048,438

G

aldo-keto reductase family 7, member A2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of AKR7A5 mRNA

NCBI chr 5:156,835,589...156,844,127
Ensembl chr 5:156,835,551...156,844,109

G

AKT serine/threonine kinase 1

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of AKT1 mRNA

NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610

G

aldolase, fructose-bisphosphate C

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ALDOC mRNA

NCBI chr10:63,715,544...63,719,133
Ensembl chr10:63,715,489...63,719,133

G

alpha-kinase 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ALPK1 mRNA

NCBI chr 2:218,801,425...218,924,013
Ensembl chr 2:218,780,189...218,921,646

G

alkaline phosphatase, placental

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of AKP3 mRNA

NCBI chr 9:95,213,763...95,216,509
Ensembl chr 9:95,213,374...95,219,451

G

angiopoietin like 7

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ANGPTL7 mRNA

NCBI chr 5:158,932,096...158,937,281
Ensembl chr 5:164,215,223...164,220,584

G

ankyrin repeat domain 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ANKRD1 mRNA

NCBI chr 1:233,815,851...233,834,891
Ensembl chr 1:243,228,448...243,263,751

G

ANKRD40 C-terminal like

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ANKRD40CL mRNA

NCBI chr10:79,227,791...79,236,365
Ensembl chr10:79,728,105...79,732,218

G

annexin A8

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ANXA8 mRNA

NCBI chr16:9,403,267...9,418,317
Ensembl chr16:9,403,353...9,418,310

G

apolipoprotein L7A

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of APOL7A mRNA

Ensembl chr 7:111,011,645...111,017,084

G

apolipoprotein L9a

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of APOL9A mRNA

NCBI chr 7:111,021,452...111,030,380
Ensembl chr 7:111,021,453...111,028,213

G

aquaporin 3 (Gill blood group)

decreases expression

ISO

monomethylarsonic acid results in decreased expression of AQP3 mRNA

NCBI chr 5:61,035,165...61,040,683
Ensembl chr 5:61,035,166...61,040,685

G

amphiregulin

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of AREG mRNA

NCBI chr14:17,256,384...17,265,641
Ensembl chr14:17,256,384...17,265,641

G

Rho GTPase activating protein 15

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ARHGAP15 mRNA

NCBI chr 3:27,989,368...28,592,722
Ensembl chr 3:48,382,904...49,011,378

G

Rho GTPase activating protein 25

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ARHGAP25 mRNA

NCBI chr 4:119,896,844...119,974,982
Ensembl chr 4:121,454,151...121,552,913

G

Rho GTPase activating protein 30

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ARHGAP30 mRNA

NCBI chr13:86,354,448...86,376,552
Ensembl chr13:86,354,547...86,376,888

G

Rho GTPase activating protein 45

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ARHGAP45 mRNA

NCBI chr 7:9,674,873...9,690,286
Ensembl chr 7:10,325,539...10,341,890

G

Rho GTPase activating protein 8

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ARHGAP8 mRNA

NCBI chr 7:117,723,512...117,782,031
Ensembl chr 7:117,730,578...117,782,030

G

Rho GDP dissociation inhibitor beta

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ARHGDIB mRNA

NCBI chr 4:171,554,139...171,573,057
Ensembl chr 4:171,554,140...171,573,068

G

Rho guanine nucleotide exchange factor 38

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ARHGEF38 mRNA

NCBI chr 2:221,610,212...221,739,841
Ensembl chr 2:224,284,238...224,413,974

G

ARF like GTPase 5C

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ARL5C mRNA

NCBI chr10:82,985,213...82,993,425
Ensembl chr10:83,481,540...83,488,406

G

ARF like GTPase 9

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ARL9 mRNA

NCBI chr14:31,157,573...31,166,803
Ensembl chr14:31,511,330...31,520,988

G

arsenite methyltransferase

increases metabolic processing
increases expression
multiple interactions
increases chemical synthesis

ISO

AS3MT protein polymorphism results in increased metabolism of monomethylarsonic acid; AS3MT protein results in increased metabolism of monomethylarsonic acid
monomethylarsonic acid results in increased expression of AS3MT protein
[AS3MT gene polymorphism affects the susceptibility to Arsenic] which results in increased abundance of monomethylarsonic acid; [AS3MT protein polymorphism results in increased metabolism of arsenite] which results in increased chemical synthesis of monomethylarsonic acid; [AS3MT protein polymorphism results in increased metabolism of monomethylarsonic acid] which results in increased chemical synthesis of Cacodylic Acid; [AS3MT protein polymorphism results in increased metabolism of monomethylarsonic acid] which results in increased chemical synthesis of dimethylarsinous acid; [AS3MT protein results in increased metabolism of arsenite] which results in increased chemical synthesis of monomethylarsonic acid; [AS3MT protein results in increased metabolism of monomethylarsonic acid] which results in increased chemical synthesis of Cacodylic Acid; [AS3MT protein results in increased metabolism of monomethylarsonic acid] which results in increased chemical synthesis of dimethylarsinous acid
AS3MT protein results in increased chemical synthesis of monomethylarsonic acid

PMID:22005461 PMID:22868225 PMID:24845704 PMID:36399430

NCBI chr 1:255,536,879...255,569,245
Ensembl chr 1:255,537,109...255,569,249

G

ankyrin repeat and SOCS box-containing 14

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ASB14 mRNA

NCBI chr16:2,095,567...2,123,259
Ensembl chr16:2,102,363...2,130,590

G

ankyrin repeat and SOCS box-containing 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ASB4 mRNA

NCBI chr 4:33,506,992...33,544,630
Ensembl chr 4:34,473,408...34,512,888

G

aspartic peptidase, retroviral-like 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ASPRV1 mRNA

NCBI chr 4:120,634,793...120,636,265
Ensembl chr 4:120,634,793...120,636,260

G

activating transcription factor 3

multiple interactions
increases expression

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ATF3 mRNA
monomethylarsonic acid results in increased expression of ATF3 mRNA; monomethylarsonic acid results in increased expression of ATF3 protein

PMID:34876320 PMID:38630284

NCBI chr13:105,274,103...105,331,653
Ensembl chr13:105,282,440...105,295,750

G

activating transcription factor 7 interacting protein 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ATF7IP2 mRNA

NCBI chr10:5,403,099...5,445,989
Ensembl chr10:5,909,658...5,952,995

G

ATPase phospholipid transporting 10D (putative)

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ATP10D mRNA

NCBI chr14:36,265,696...36,366,460
Ensembl chr14:36,265,696...36,366,460

G

ATPase copper transporting beta

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ATP7B mRNA

NCBI chr16:76,654,725...76,726,092
Ensembl chr16:76,653,660...76,728,801

G

Beta-1,3-galactosyltransferase 5

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of B3GALT5 mRNA

NCBI chr11:35,584,273...35,630,922
Ensembl chr11:49,006,560...49,101,283

G

UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of B3GNT5 mRNA

NCBI chr11:81,141,102...81,153,206
Ensembl chr11:94,645,480...94,660,514

G

B-cell scaffold protein with ankyrin repeats 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of BANK1 mRNA

NCBI chr 2:224,530,475...224,800,420
Ensembl chr 2:227,203,998...227,474,037

G

Btg3 associated nuclear protein

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of BANP mRNA

NCBI chr19:66,916,417...66,994,286
Ensembl chr19:66,916,267...66,991,317

G

BCL6 co-repressor-like 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of BCORL1 mRNA

NCBI chr X:132,394,703...132,462,414
Ensembl chr X:132,397,069...132,461,976

G

bifunctional apoptosis regulator

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of BFAR mRNA

NCBI chr10:1,552,019...1,585,040
Ensembl chr10:2,059,058...2,094,183

G

basic helix-loop-helix family, member e41

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of BHLHE41 mRNA

NCBI chr 4:180,565,003...180,569,415
Ensembl chr 4:180,565,003...180,569,355

G

BLK proto-oncogene, Src family tyrosine kinase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of BLK mRNA

NCBI chr15:41,802,701...41,841,004
Ensembl chr15:41,802,994...41,840,982

G

basic helix-loop-helix ARNT like 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of BMAL1 mRNA

NCBI chr 1:176,766,222...176,864,741
Ensembl chr 1:176,829,305...176,864,739

G

Bri3 binding protein

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of BRI3BP mRNA

NCBI chr12:31,176,742...31,188,563
Ensembl chr12:36,838,098...36,849,919

G

bromodomain and WD repeat domain containing 3

increases expression

ISO

monomethylarsonic acid results in increased expression of BRWD3 mRNA

NCBI chr X:77,843,766...77,937,240
Ensembl chr X:77,848,982...77,937,745

G

Bruton tyrosine kinase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of BTK mRNA

NCBI chr X:102,016,070...102,055,448
Ensembl chr X:102,016,074...102,055,143

G

B and T lymphocyte associated

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of BTLA mRNA

NCBI chr11:55,563,683...55,588,187
Ensembl chr11:69,052,644...69,093,224

G

C1q and TNF related 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of C1QTNF3 mRNA

NCBI chr 2:61,644,225...61,666,640
Ensembl chr 2:61,644,276...61,666,559

G

similar to human chromosome 19 open reading frame 38

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of AB124611 mRNA

NCBI chr 8:20,061,494...20,095,705
Ensembl chr 8:28,354,725...28,371,804

G

calcium voltage-gated channel subunit alpha1 I

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CACNA1I mRNA

NCBI chr 7:113,716,266...113,827,670
Ensembl chr 7:113,716,266...113,827,670

G

calcium/calmodulin-dependent protein kinase IG

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CAMK1G mRNA

NCBI chr13:104,877,909...104,901,658
Ensembl chr13:107,406,584...107,430,230

G

calpain 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CAPN3 mRNA

NCBI chr 3:127,860,002...127,913,677
Ensembl chr 3:127,861,589...127,911,638

G

caspase recruitment domain family, member 11

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CARD11 mRNA

NCBI chr12:18,735,088...18,872,045
Ensembl chr12:18,735,088...18,872,045

G

capping protein regulator and myosin 1 linker 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CARMIL2 mRNA

NCBI chr19:50,481,911...50,496,672
Ensembl chr19:50,484,324...50,496,669

G

caspase 3

affects response to substance
multiple interactions
increases expression

EXP
ISO

CASP3 protein affects the susceptibility to monomethylarsonic acid
[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of CASP3 mRNA
monomethylarsonic acid results in increased expression of CASP3 mRNA
[monomethylarsonic acid co-treated with Buthionine Sulfoximine] results in increased activity of CASP3 protein

PMID:15963344 PMID:17481689 PMID:23192986

NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732

G

catalase

multiple interactions

EXP

[CAT protein results in decreased oxidation of monomethylarsonous acid] which results in decreased chemical synthesis of monomethylarsonic acid

NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526

G

cation channel, sperm associated 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of CATSPER4 mRNA

NCBI chr 5:151,711,415...151,731,083
Ensembl chr 5:151,711,194...151,730,750

G

coiled-coil domain containing 122

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CCDC122 mRNA

NCBI chr15:52,407,717...52,470,163
Ensembl chr15:58,816,873...58,879,592

G

coiled-coil domain containing 162

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CCDC162 mRNA

NCBI chr20:45,044,891...45,237,905
Ensembl chr20:46,627,277...46,818,249

G

coiled-coil domain containing 71-like

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of CCDC71L mRNA

NCBI chr 6:48,960,020...48,964,112
Ensembl chr 6:54,617,540...55,014,344

G

coiled-coil domain containing 78

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CCDC78 mRNA

NCBI chr10:15,312,403...15,316,800
Ensembl chr10:15,311,868...15,319,425

G

coiled-coil domain containing 87

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CCDC87 mRNA

NCBI chr 1:202,135,021...202,137,717
Ensembl chr 1:211,475,789...211,568,008

G

coiled-coil domain containing 88C

decreases expression

ISO

monomethylarsonic acid results in decreased expression of CCDC88C mRNA

NCBI chr 6:125,899,337...126,019,162
Ensembl chr 6:125,899,526...126,018,865

G

coiled-coil domain containing 92B

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CCDC92B mRNA

NCBI chr10:59,479,798...59,501,486
Ensembl chr10:59,978,203...59,999,887

G

C-C motif chemokine ligand 22

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CCL22 mRNA

NCBI chr19:10,263,589...10,270,359
Ensembl chr19:10,263,589...10,270,359

G

cellular communication network factor 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of CCN1 mRNA

NCBI chr 2:237,222,730...237,225,689
Ensembl chr 2:237,222,432...237,225,883

G

cyclin D1

increases expression

EXP

monomethylarsonic acid results in increased expression of CCND1 mRNA

NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810

G

cyclin E1

increases expression

EXP

monomethylarsonic acid results in increased expression of CCNE1 mRNA

NCBI chr 1:99,918,672...99,927,986
Ensembl chr 1:99,918,674...99,927,822

G

C-C motif chemokine receptor 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CCR6 mRNA

NCBI chr 1:55,022,037...55,055,857
Ensembl chr 1:55,021,833...55,046,059

G

C-C motif chemokine receptor 7

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CCR7 mRNA

NCBI chr10:84,594,399...84,604,514
Ensembl chr10:84,593,594...84,604,501

G

CD180 molecule

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD180 mRNA

NCBI chr 2:35,589,889...35,602,837
Ensembl chr 2:35,589,451...35,603,982

G

Cd2 molecule

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD2 mRNA

NCBI chr 2:188,710,895...188,724,044
Ensembl chr 2:191,399,510...191,413,665

G

CD22 molecule

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD22 mRNA

NCBI chr 1:95,243,785...95,270,430
Ensembl chr 1:95,244,868...95,259,730

G

Cd28 molecule

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD28 mRNA

NCBI chr 9:69,660,316...69,689,192
Ensembl chr 9:69,545,326...69,689,192

G

CD37 molecule

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD37 mRNA

NCBI chr 1:104,855,622...104,861,111
Ensembl chr 1:104,849,166...104,861,276

G

CD40 molecule

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD40 mRNA

NCBI chr 3:174,209,113...174,224,592
Ensembl chr 3:174,209,719...174,224,847

G

CD46 molecule

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD46 mRNA

NCBI chr13:109,104,122...109,134,903

G

Cd5 molecule

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD5 mRNA

NCBI chr 1:216,790,245...216,811,209
Ensembl chr 1:216,790,245...216,811,209

G

CD52 molecule

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD52 mRNA

NCBI chr 5:151,603,537...151,605,096
Ensembl chr 5:151,603,524...151,605,086

G

Cd53 molecule

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD53 mRNA

NCBI chr 2:197,040,369...197,087,925
Ensembl chr 2:197,040,369...197,218,593

G

Cd6 molecule

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD6 mRNA

NCBI chr 1:216,867,767...216,906,642
Ensembl chr 1:216,867,771...216,879,432

G

Cd69 molecule

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD69 mRNA

NCBI chr 4:164,411,485...164,419,403
Ensembl chr 4:164,411,485...164,419,509

G

CD79a molecule

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD79A mRNA

NCBI chr 1:89,621,460...89,625,813
Ensembl chr 1:89,621,460...89,625,812

G

CD79b molecule

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD79B mRNA

NCBI chr10:91,739,134...91,742,312
Ensembl chr10:91,739,137...91,742,405

G

CD83 molecule

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD83 mRNA

NCBI chr17:21,093,281...21,113,223
Ensembl chr17:21,093,281...21,113,047

G

CD84 molecule

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD84 mRNA

NCBI chr13:86,859,979...86,899,984
Ensembl chr13:86,859,990...86,894,318

G

CD86 molecule

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD86 mRNA

NCBI chr11:77,647,565...77,706,178
Ensembl chr11:77,647,600...77,725,361

G

cell division cycle 25B

decreases activity

ISO

monomethylarsonic acid results in decreased activity of CDC25B protein

NCBI chr 3:118,407,127...118,417,272
Ensembl chr 3:138,860,130...138,870,492

G

CDC42 effector protein 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of CDC42EP2 mRNA

NCBI chr 1:203,202,000...203,210,891
Ensembl chr 1:212,629,881...212,640,234

G

cadherin 1

increases expression

EXP

monomethylarsonic acid results in increased expression of CDH1 mRNA

NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565

G

cadherin 2

increases expression

EXP

monomethylarsonic acid results in increased expression of CDH2 mRNA

NCBI chr18:8,051,097...8,265,288
Ensembl chr18:8,051,097...8,265,288

G

cyclin dependent kinase like 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CDKL1 mRNA

NCBI chr 6:88,224,154...88,273,434
Ensembl chr 6:93,959,911...94,006,115

G

cyclin-dependent kinase inhibitor 1A

decreases expression
multiple interactions

EXP
ISO

monomethylarsonic acid results in decreased expression of CDKN1A mRNA
[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of CDKN1A mRNA

PMID:17481689 PMID:23192986

NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969

G

CECR2, histone acetyl-lysine reader

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CECR2 mRNA

NCBI chr 4:155,562,576...155,670,253
Ensembl chr 4:155,562,727...155,666,741

G

carboxylesterase 2F

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CES2F mRNA

NCBI chr19:7,527...14,898
Ensembl chr19:13,987...21,358

G

cilia and flagella associated protein 47

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CFAP47 mRNA

NCBI chr X:47,149,085...47,504,169
Ensembl chr X:47,149,334...47,504,257

G

ChaC glutathione-specific gamma-glutamylcyclotransferase 1

increases expression

ISO

monomethylarsonic acid results in increased expression of CHAC1 mRNA

NCBI chr 3:126,796,131...126,799,352
Ensembl chr 3:126,796,024...126,799,361

G

chondroadherin

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of CHAD mRNA

NCBI chr10:79,512,170...79,515,941
Ensembl chr10:80,008,767...80,012,816

G

cysteine and histidine rich domain containing 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of CHORDC1 mRNA

NCBI chr 8:23,650,721...23,674,786
Ensembl chr 8:23,650,865...23,677,696

G

cholinergic receptor nicotinic alpha 9 subunit

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of CHRNA9 mRNA

NCBI chr14:42,588,948...42,595,669
Ensembl chr14:42,588,948...42,595,669

G

carbohydrate sulfotransferase 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CHST3 mRNA

NCBI chr20:28,657,308...28,694,976
Ensembl chr20:28,657,308...28,694,526

G

circadian associated repressor of transcription

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CIART mRNA

NCBI chr 2:186,108,744...186,113,778
Ensembl chr 2:186,108,752...186,112,246

G

class II, major histocompatibility complex, transactivator

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CIITA mRNA

NCBI chr10:5,646,854...5,694,393
Ensembl chr10:5,647,085...5,694,342

G

cartilage intermediate layer protein

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CILP mRNA

NCBI chr 8:74,671,696...74,687,420
Ensembl chr 8:74,671,534...74,687,409

G

cold inducible RNA binding protein

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CIRBP mRNA

NCBI chr 7:10,184,515...10,189,623

G

Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2

increases expression

ISO

monomethylarsonic acid results in increased expression of CITED2 mRNA

NCBI chr 1:14,132,303...14,134,746
Ensembl chr 1:14,103,457...14,134,782

G

chloride channel accessory 4

decreases expression

ISO

monomethylarsonic acid results in decreased expression of CLCA4 mRNA

NCBI chr 2:236,543,975...236,565,096
Ensembl chr 2:236,544,201...236,563,435

G

cardiotrophin-like cytokine factor 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CLCF1 mRNA

NCBI chr 1:210,937,763...210,947,064
Ensembl chr 1:210,937,255...210,947,064

G

C-type lectin domain containing 7A

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CLEC7A mRNA

NCBI chr 4:164,588,737...164,599,953
Ensembl chr 4:164,588,754...164,599,919

G

clusterin

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CLU mRNA

NCBI chr15:44,336,619...44,375,861
Ensembl chr15:44,359,914...44,375,860

G

cannabinoid receptor 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CNR2 mRNA

NCBI chr 5:153,408,968...153,435,092
Ensembl chr 5:153,409,147...153,435,961

G

cochlin

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of COCH mRNA

NCBI chr 6:74,766,485...74,780,504
Ensembl chr 6:74,766,419...74,780,502

G

collagen type XI alpha 2 chain

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of COL11A2 mRNA

NCBI chr20:4,788,829...4,818,492
Ensembl chr20:4,788,829...4,817,648

G

collagen type VII alpha 1 chain

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of COL7A1 mRNA

NCBI chr 8:118,483,364...118,515,736
Ensembl chr 8:118,483,364...118,517,439

G

collagen like tail subunit of asymmetric acetylcholinesterase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of COLQ mRNA

NCBI chr16:6,738,251...6,830,492
Ensembl chr16:6,738,251...6,793,501

G

coronin 1A

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CORO1A mRNA

NCBI chr 1:190,726,129...190,731,133
Ensembl chr 1:190,726,130...190,731,102

G

coactosin-like F-actin binding protein 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of COTL1 mRNA

NCBI chr19:64,780,309...64,814,629
Ensembl chr19:64,780,322...64,814,840

G

cleavage and polyadenylation specific factor 4-like

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of CPSF4L mRNA

NCBI chr10:98,741,816...98,756,069
Ensembl chr10:99,242,794...99,257,172

G

carboxypeptidase X (M14 family), member 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CPXM1 mRNA

NCBI chr 3:117,588,532...117,595,330
Ensembl chr 3:138,041,645...138,048,857

G

complement C3d receptor 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CR2 mRNA

NCBI chr13:109,207,034...109,244,980
Ensembl chr13:109,213,867...109,244,552

G

CDP-L-ribitol pyrophosphorylase A

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CRPPA mRNA

NCBI chr 6:58,847,550...59,124,309
Ensembl chr 6:58,848,621...59,181,406

G

cytotoxic and regulatory T cell molecule

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CRTAM mRNA

NCBI chr 8:50,237,210...50,274,472
Ensembl chr 8:50,237,210...50,274,472

G

cryptochrome circadian regulator 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of CRY1 mRNA

NCBI chr 7:20,417,526...20,481,791
Ensembl chr 7:20,417,107...20,481,822

G

cysteine and serine rich nuclear protein 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CSRNP2 mRNA

NCBI chr 7:131,594,232...131,610,075
Ensembl chr 7:133,473,027...133,488,868

G

catenin alpha 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CTNNA3 mRNA

NCBI chr20:23,614,469...25,200,026
Ensembl chr20:23,613,016...25,198,805

G

C-X-C motif chemokine ligand 10

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CXCL10 mRNA

NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,989,018...15,991,261

G

C-X-C motif chemokine ligand 9

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CXCL9 mRNA

NCBI chr14:16,007,166...16,012,077
Ensembl chr14:16,007,204...16,014,299

G

cytochrome b-245 beta chain

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CYBB mRNA

NCBI chr X:16,030,596...16,065,065
Ensembl chr X:16,030,596...16,065,065

G

cytochrome P450, family 1, subfamily a, polypeptide 1

multiple interactions
increases expression

ISO

AHR mutant form inhibits the reaction [monomethylarsonic acid results in increased expression of CYP1A1 protein]; monomethylarsonic acid promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A1 protein]; monomethylarsonic acid promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; monomethylarsonic acid results in increased expression of and results in increased activity of CYP1A1 protein
[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of CYP1A1 mRNA
monomethylarsonic acid results in increased expression of CYP1A1 mRNA

PMID:24161444 PMID:34876320

NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012

G

cytochrome P450, family 1, subfamily a, polypeptide 2

increases expression

EXP

monomethylarsonic acid results in increased expression of CYP1A2 mRNA

NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149

G

cytochrome P450, family 2, subfamily b, polypeptide 1

multiple interactions
increases expression

EXP

[monomethylarsonic acid co-treated with Diethylnitrosamine] results in increased expression of CYP2B1 mRNA; [monomethylarsonic acid co-treated with Diethylnitrosamine] results in increased expression of CYP2B1 protein
monomethylarsonic acid results in increased expression of CYP2B1 mRNA

PMID:12115560 PMID:17481689

NCBI chr 1:90,646,098...90,669,762

G

cytochrome P450, family 2, subfamily b, polypeptide 2

multiple interactions

EXP

[monomethylarsonic acid co-treated with Diethylnitrosamine] results in increased expression of CYP2B2 mRNA

NCBI chr 1:90,722,243...90,736,272

G

cytochrome P450, subfamily 2, polypeptide 11

increases expression

EXP

monomethylarsonic acid results in increased expression of CYP2C11 mRNA

NCBI chr 1:246,175,216...246,211,445
Ensembl chr 1:246,174,711...246,211,853

G

cytochrome P450, family 4, subfamily f, polypeptide 18

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CYP4F18 mRNA

NCBI chr16:17,797,558...17,838,958
Ensembl chr16:17,740,001...17,838,958

G

DAB adaptor protein 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DAB1 mRNA

NCBI chr 5:123,621,510...124,742,585
Ensembl chr 5:124,369,415...124,742,584

G

D-box binding PAR bZIP transcription factor

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DBP mRNA

NCBI chr 1:105,312,256...105,317,205
Ensembl chr 1:105,312,108...105,317,205

G

doublecortin-like kinase 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DCLK3 mRNA

NCBI chr 8:111,401,544...111,453,999
Ensembl chr 8:120,279,757...120,332,432

G

damage specific DNA binding protein 2

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of DDB2 mRNA

NCBI chr 3:77,185,114...77,207,650
Ensembl chr 3:97,640,579...97,664,066

G

DNA-damage inducible transcript 3

increases expression

ISO

monomethylarsonic acid results in increased expression of DDIT3 protein

NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509

G

DEF6 guanine nucleotide exchange factor

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DEF6 mRNA

NCBI chr20:6,268,579...6,290,030
Ensembl chr20:6,269,357...6,291,771

G

defensin alpha 5

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of DEFA21 mRNA

NCBI chr16:77,044,994...77,047,318
Ensembl chr16:77,044,994...77,047,318

G

7-dehydrocholesterol reductase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DHCR7 mRNA

NCBI chr 1:208,444,434...208,460,408
Ensembl chr 1:208,444,434...208,461,382

G

dehydrogenase/reductase 11

decreases expression

ISO

monomethylarsonic acid results in decreased expression of DHRS11 mRNA

NCBI chr10:70,195,637...70,205,735
Ensembl chr10:70,195,637...70,205,893

G

dehydrogenase/reductase 9

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of DHRS9 mRNA

NCBI chr 3:54,147,834...54,170,052
Ensembl chr 3:74,555,606...74,581,376

G

DIRAS family GTPase 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DIRAS2 mRNA

NCBI chr17:12,730,040...12,761,511
Ensembl chr17:12,880,385...12,914,291

G

dynein, axonemal, heavy chain 10

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of DNAH10 mRNA

NCBI chr12:31,823,451...31,946,857
Ensembl chr12:37,472,813...37,640,860

G

dynein axonemal intermediate chain 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of DNAI4 mRNA

NCBI chr 5:117,787,398...117,876,216
Ensembl chr 5:123,016,480...123,105,283

G

DnaJ heat shock protein family (Hsp40) member B13

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DNAJB13 mRNA

NCBI chr 1:154,848,586...154,863,042
Ensembl chr 1:164,260,724...164,275,093

G

DnaJ heat shock protein family (Hsp40) member B3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DNAJB3 mRNA

NCBI chr 9:88,795,542...88,796,555
Ensembl chr 9:96,243,071...96,244,408

G

deoxyribonuclease 1 like 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of DNASE1L2 mRNA

NCBI chr10:13,976,012...13,978,574
Ensembl chr10:13,976,012...13,978,366

G

deoxyribonuclease 1L3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DNASE1L3 mRNA

NCBI chr15:19,351,683...19,378,536
Ensembl chr15:19,352,493...19,378,531

G

DNA methyltransferase 1

decreases expression

EXP

monomethylarsonic acid results in decreased expression of DNMT1 mRNA

NCBI chr 8:27,716,797...27,763,405
Ensembl chr 8:27,716,797...27,763,119

G

dedicator of cytokinesis 10

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DOCK10 mRNA

NCBI chr 9:89,291,936...89,549,871
Ensembl chr 9:89,291,800...89,549,973

G

dedicator of cytokinesis 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DOCK2 mRNA

NCBI chr10:18,827,237...19,244,832
Ensembl chr10:19,331,412...19,748,969

G

docking protein 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DOK3 mRNA

NCBI chr17:9,114,763...9,121,781
Ensembl chr17:9,114,762...9,120,335

G

dopamine receptor D3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of DRD3 mRNA

NCBI chr11:70,385,586...70,437,793
Ensembl chr11:70,385,586...70,446,760

G

dual oxidase 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of DUOX2 mRNA

NCBI chr 3:129,680,543...129,698,886
Ensembl chr 3:129,680,546...129,699,203

G

dual oxidase maturation factor 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of DUOXA1 mRNA

NCBI chr 3:129,703,416...129,714,110
Ensembl chr 3:129,703,416...129,706,829

G

dual oxidase maturation factor 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of DUOXA2 mRNA

NCBI chr 3:129,698,938...129,702,656
Ensembl chr 3:129,698,092...129,702,656

G

dual specificity phosphatase 1

multiple interactions
increases expression

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of DUSP1 mRNA
monomethylarsonic acid results in increased expression of DUSP1 mRNA

PMID:34876320 PMID:38630284

NCBI chr10:17,184,853...17,187,646
Ensembl chr10:17,184,823...17,187,644

G

dual specificity phosphatase 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DUSP2 mRNA

NCBI chr 3:135,009,636...135,011,821
Ensembl chr 3:135,009,590...135,011,809

G

dual specificity phosphatase 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of DUSP6 mRNA

NCBI chr 7:35,979,502...35,983,834
Ensembl chr 7:35,977,921...35,983,833

G

ELL associated factor 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of EAF2 mRNA

NCBI chr11:77,465,585...77,509,993
Ensembl chr11:77,406,020...77,509,993

G

endothelin 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of EDN1 mRNA

NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,660,799...22,666,687

G

ephrin A3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of EFNA3 mRNA

NCBI chr 2:174,729,192...174,738,111
Ensembl chr 2:177,026,933...177,044,843

G

early growth response 1

increases expression
multiple interactions

ISO

monomethylarsonic acid results in increased expression of EGR1 mRNA
[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of EGR1 mRNA

PMID:15345372 PMID:23192986

NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,736,838...26,740,843

G

early growth response 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of EGR3 mRNA

NCBI chr15:51,560,482...51,565,778
Ensembl chr15:51,560,344...51,565,712

G

extracellular leucine-rich repeat and fibronectin type III domain containing 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ELFN2 mRNA

NCBI chr 7:110,220,293...110,272,770
Ensembl chr 7:112,074,331...112,153,451

G

endonuclease, poly(U)-specific

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ENDOU mRNA

NCBI chr 7:128,844,872...128,866,572
Ensembl chr 7:130,723,972...130,745,672

G

eomesodermin

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of EOMES mRNA

NCBI chr 8:127,059,215...127,067,070
Ensembl chr 8:127,059,215...127,067,070

G

EPM2A glucan phosphatase, laforin

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of EPM2A mRNA

NCBI chr 1:7,547,369...7,673,449
Ensembl chr 1:7,547,342...7,669,604

G

epiregulin

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of EREG mRNA

NCBI chr14:17,311,485...17,325,260
Ensembl chr14:17,311,485...17,325,260

G

endogenous retrovirus group FRD member 1, envelope

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SYNA mRNA

NCBI chr12:27,787,680...27,794,732
Ensembl chr12:27,787,680...27,794,732

G

estrogen receptor 1

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of ESR1 mRNA

NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354

G

ethanolamine kinase 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ETNK2 mRNA

NCBI chr13:47,362,964...47,381,100
Ensembl chr13:47,363,060...47,381,100

G

ETS proto-oncogene 1, transcription factor

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ETS1 mRNA

NCBI chr 8:39,303,936...39,426,022
Ensembl chr 8:39,303,925...39,426,021

G

exophilin 5

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of EXPH5 mRNA

NCBI chr 8:62,595,116...62,671,575
Ensembl chr 8:62,595,116...62,671,575

G

fatty acid binding protein 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FABP1 mRNA

NCBI chr 4:104,744,302...104,753,119
Ensembl chr 4:104,744,309...104,753,113

G

fatty acid binding protein 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FABP3 mRNA

NCBI chr 5:147,936,027...147,942,870
Ensembl chr 5:147,936,119...147,942,881

G

fatty acid desaturase 3

increases expression

ISO

monomethylarsonic acid results in increased expression of FADS3 mRNA

NCBI chr 1:216,110,547...216,127,431
Ensembl chr 1:216,110,201...216,141,758

G

family with sequence similarity 151, member A

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of FAM151A mRNA

NCBI chr 5:121,514,804...121,527,555
Ensembl chr 5:126,743,555...126,756,373

G

FAM161 centrosomal protein B

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of FAM161B mRNA

NCBI chr 6:103,990,603...104,007,754
Ensembl chr 6:109,722,569...109,750,036

G

family with sequence similarity 169, member B

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FAM169B mRNA

NCBI chr 1:121,878,670...121,968,272
Ensembl chr 1:131,288,799...131,370,145

G

family with sequence similarity 89, member A

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FAM89A mRNA

NCBI chr19:69,607,391...69,620,019
Ensembl chr19:69,607,391...69,620,019

G

FA complementation group D2

multiple interactions

ISO

[monomethylarsonic acid results in decreased activity of FANCD2 protein] which results in increased susceptibility to diepoxybutane; [monomethylarsonic acid results in decreased activity of FANCD2 protein] which results in increased susceptibility to Hydroxyurea; [monomethylarsonic acid results in decreased activity of FANCD2 protein] which results in increased susceptibility to Mitomycin

NCBI chr 4:148,234,633...148,299,035
Ensembl chr 4:148,234,708...148,299,035

G

Fas cell surface death receptor

decreases expression

ISO

monomethylarsonic acid results in decreased expression of FAS mRNA

NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:241,205,935...241,246,104

G

Fas ligand

increases expression

EXP

monomethylarsonic acid results in increased expression of FASLG mRNA

NCBI chr13:76,680,885...76,706,042
Ensembl chr13:76,688,243...76,695,503

G

fructose-bisphosphatase 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FBP1 mRNA

NCBI chr17:2,212,941...2,235,749
Ensembl chr17:2,213,492...2,235,746

G

F-box and leucine-rich repeat protein 22

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of FBXL22 mRNA

NCBI chr 8:75,965,027...75,971,714
Ensembl chr 8:75,965,027...75,971,714

G

F-box protein 24

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of FBXO24 mRNA

NCBI chr12:19,072,668...19,083,067
Ensembl chr12:24,709,468...24,719,848

G

Fc epsilon receptor II

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FCER2A mRNA

NCBI chr12:6,540,697...6,552,364
Ensembl chr12:6,540,703...6,549,374

G

Fc receptor-like A

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FCRLA mRNA

NCBI chr13:85,693,177...85,702,875
Ensembl chr13:85,693,122...85,703,176

G

farnesyl diphosphate farnesyl transferase 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FDFT1 mRNA

NCBI chr15:41,588,114...41,616,168
Ensembl chr15:41,588,117...41,616,168

G

farnesyl diphosphate synthase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FDPS mRNA

NCBI chr 2:176,795,192...176,804,816
Ensembl chr 2:176,795,192...176,807,136

G

fer-1-like family member 5

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of FER1L5 mRNA

NCBI chr 9:46,101,798...46,156,483
Ensembl chr 9:46,103,760...46,156,479

G

free fatty acid receptor 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FFAR1 mRNA

NCBI chr 1:95,238,785...95,239,689
Ensembl chr 1:95,238,785...95,239,691

G

fibroblast growth factor 11

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of FGF11 mRNA

NCBI chr10:55,015,232...55,020,773
Ensembl chr10:55,016,411...55,020,454

G

fibroblast growth factor 2

increases expression

ISO

monomethylarsonic acid results in increased expression of FGF2 mRNA

NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:122,164,454...122,224,493

G

fibroblast growth factor binding protein 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FGFBP3 mRNA

NCBI chr 1:234,644,023...234,646,028
Ensembl chr 1:244,056,307...244,065,654

G

FGR proto-oncogene, Src family tyrosine kinase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FGR mRNA

NCBI chr 5:150,473,767...150,503,524
Ensembl chr 5:150,473,792...150,503,169

G

FKBP prolyl isomerase 5

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of FKBP5 mRNA

NCBI chr20:6,458,931...6,577,227
Ensembl chr20:6,458,940...6,543,118

G

flagellum associated containing coiled-coil domains 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FLACC1 mRNA

NCBI chr 9:67,809,731...67,837,793
Ensembl chr 9:67,809,739...67,837,793

G

Fli-1 proto-oncogene, ETS transcription factor

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FLI1 mRNA

NCBI chr 8:39,089,526...39,209,511
Ensembl chr 8:39,089,533...39,208,557

G

filamin C

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FLNC mRNA

NCBI chr 4:58,999,445...59,027,240
Ensembl chr 4:58,999,547...59,027,240

G

Fms related receptor tyrosine kinase 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FLT3 mRNA

NCBI chr12:12,660,035...12,735,584
Ensembl chr12:12,659,946...12,735,581

G

fibronectin type III domain containing 10

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FNDC10 mRNA

NCBI chr 5:171,581,960...171,584,519
Ensembl chr 5:171,580,033...171,595,399

G

Fos proto-oncogene, AP-1 transcription factor subunit

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of FOS mRNA
[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of FOS mRNA

PMID:23192986 PMID:34876320

NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598

G

formyl peptide receptor 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of FPR1 mRNA

NCBI chr 1:58,745,019...58,756,776
Ensembl chr 1:67,421,313...67,422,520

G

fascin actin-bundling protein 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FSCN1 mRNA

NCBI chr12:16,710,601...16,723,734
Ensembl chr12:16,710,601...16,723,734

G

ferritin light chain 1

increases expression

ISO

monomethylarsonic acid results in increased expression of FTL mRNA

NCBI chr 1:105,072,858...105,074,705
Ensembl chr X:45,399,355...45,399,915
Ensembl chr 2:45,399,355...45,399,915
Ensembl chr 1:45,399,355...45,399,915

G

fucosyltransferase 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of FUT1 mRNA

NCBI chr 1:96,086,934...96,090,352
Ensembl chr 1:105,223,390...105,227,513

G

growth arrest and DNA-damage-inducible, alpha

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of GADD45A mRNA

NCBI chr 4:97,484,497...97,486,799
Ensembl chr 4:97,484,502...97,486,807

G

guanylate binding protein 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GBP4 mRNA

NCBI chr 2:233,978,163...233,992,124
Ensembl chr 2:233,978,486...233,992,120

G

guanylate binding protein family member 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GBP9 mRNA

NCBI chr14:4,730,286...4,756,508
Ensembl chr14:4,968,325...4,983,692
Ensembl chr14:4,968,325...4,983,692

G

GTP cyclohydrolase 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of GCH1 mRNA

NCBI chr15:22,884,006...22,917,412
Ensembl chr15:22,884,006...22,917,412

G

germinal center-associated, signaling and motility

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GCSAM mRNA

NCBI chr11:55,195,757...55,207,011
Ensembl chr11:68,660,438...68,669,584

G

growth differentiation factor 15

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GDF15 mRNA

NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,838,436...18,842,022

G

GTPase, IMAP family member 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GIMAP6 mRNA

NCBI chr 4:78,984,597...78,990,006
Ensembl chr 4:78,983,504...78,990,010

G

GTPase, IMAP family member 8

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GIMAP8 mRNA

NCBI chr 4:77,600,104...77,611,593
Ensembl chr 4:78,931,029...78,942,488

G

gap junction protein, beta 1

increases expression

EXP

monomethylarsonic acid results in increased expression of GJB1 mRNA

NCBI chr X:70,541,845...70,549,776
Ensembl chr X:70,541,862...70,549,843

G

GLI family zinc finger 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GLI1 mRNA

NCBI chr 7:65,042,237...65,054,888
Ensembl chr 7:65,042,237...65,054,540

G

glycine receptor, beta

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of GLRB mRNA

NCBI chr 2:168,432,736...168,505,614
Ensembl chr 2:168,432,736...168,505,614

G

G protein subunit alpha 15

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GNA15 mRNA

NCBI chr 7:8,835,396...8,856,269
Ensembl chr 7:8,835,357...8,856,268

G

G protein subunit alpha transducin 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GNAT1 mRNA

NCBI chr 8:117,229,575...117,234,311
Ensembl chr 8:117,229,575...117,234,311

G

G protein-coupled receptor 132

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GPR132 mRNA

NCBI chr 6:131,924,061...131,943,327
Ensembl chr 6:137,745,241...137,763,157

G

G protein-coupled receptor 141

decreases expression

ISO

monomethylarsonic acid results in decreased expression of GPR141 mRNA

NCBI chr17:45,117,818...45,180,053
Ensembl chr17:49,733,713...49,875,719

G

G protein-coupled receptor 157

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GPR157 mRNA

NCBI chr 5:160,550,703...160,566,432
Ensembl chr 5:165,833,673...165,851,280

G

G protein-coupled receptor 17

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of GPR17 mRNA

NCBI chr18:23,850,460...23,857,381
Ensembl chr18:23,850,107...23,857,702

G

G protein-coupled receptor 174

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GPR174 mRNA

NCBI chr X:76,428,274...76,469,020
Ensembl chr X:76,377,973...76,468,985

G

G protein-coupled receptor 179

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GPR179 mRNA

NCBI chr10:82,820,954...82,836,833
Ensembl chr10:82,821,113...82,836,833

G

G protein-coupled receptor 18

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GPR18 mRNA

NCBI chr15:105,404,062...105,407,812
Ensembl chr15:105,404,077...105,408,836

G

G protein-coupled receptor 183

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GPR183 mRNA

NCBI chr15:105,445,129...105,457,192
Ensembl chr15:105,437,561...105,466,977

G

G protein-coupled receptor 34

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GPR34 mRNA

NCBI chr X:9,104,829...9,113,796
Ensembl chr X:11,776,371...11,843,240

G

glutathione peroxidase 7

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of GPX7 mRNA

NCBI chr 5:128,373,881...128,381,866
Ensembl chr 5:128,372,875...128,381,725

G

GRAM domain containing 2A

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GRAMD2A mRNA

NCBI chr 8:60,079,744...60,117,788
Ensembl chr 8:69,003,807...69,013,573

G

GRB2-related adaptor protein

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GRAP mRNA

NCBI chr10:46,798,423...46,851,524
Ensembl chr10:46,832,390...46,851,523

G

glutathione S-transferase alpha 2

increases expression
decreases expression

EXP
ISO

monomethylarsonic acid results in increased expression of GSTA2 mRNA
monomethylarsonic acid results in decreased expression of GSTA2 mRNA; monomethylarsonic acid results in decreased expression of GSTA2 protein

PMID:15345372 PMID:16436460 PMID:17481689

NCBI chr 8:88,064,829...88,077,168
Ensembl chr 8:88,064,616...88,077,092

G

glutathione S-transferase mu 1

increases expression

EXP

monomethylarsonic acid results in increased expression of GSTM1 mRNA; monomethylarsonic acid results in increased expression of GSTM1 protein

NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:198,338,008...198,343,569

G

glutathione S-transferase omega 1

multiple interactions
increases reduction

ISO

[GSTO1 protein results in increased metabolism of monomethylarsonic acid] which results in increased chemical synthesis of monomethylarsonous acid
GSTO1 protein results in increased reduction of monomethylarsonic acid

PMID:12928150 PMID:15929903

NCBI chr 1:256,662,377...256,672,515
Ensembl chr 1:256,662,531...256,676,167

G

glutathione S-transferase pi 1

increases expression

EXP

monomethylarsonic acid results in increased expression of GSTP1 mRNA; monomethylarsonic acid results in increased expression of GSTP2 mRNA; monomethylarsonic acid results in increased expression of GSTP2 protein

PMID:16436460 PMID:17481689

NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:210,767,237...210,769,705

G

glutathione S-transferase theta 1

affects methylation
multiple interactions

ISO

GSTT1 protein affects the methylation of monomethylarsonic acid
[GSTT1 gene polymorphism affects the metabolism of Arsenic] which affects the abundance of monomethylarsonic acid

PMID:17431481 PMID:32650499

NCBI chr20:12,856,068...12,873,020
Ensembl chr20:12,856,083...12,873,019

G

guanylate cyclase activator 1B

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of GUCA1B mRNA

NCBI chr 9:21,097,274...21,105,107
Ensembl chr 9:21,097,274...21,105,107

G

granzyme A

decreases expression

ISO

monomethylarsonic acid results in decreased expression of GZMA mRNA

NCBI chr 2:46,473,763...46,485,696
Ensembl chr 2:46,473,763...46,485,696

G

granzyme K

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GZMK mRNA

NCBI chr 2:46,573,997...46,582,015
Ensembl chr 2:46,573,997...46,582,015

G

3-hydroxyanthranilate 3,4-dioxygenase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HAAO mRNA

NCBI chr 6:10,845,235...10,864,863
Ensembl chr 6:16,598,087...16,617,356

G

hematopoietic cell specific Lyn substrate 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HCLS1 mRNA

NCBI chr11:77,322,873...77,346,333
Ensembl chr11:77,322,873...77,346,387

G

hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HCN2 mRNA

NCBI chr 7:10,620,422...10,639,457
Ensembl chr 7:10,620,422...10,639,457

G

histidine decarboxylase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HDC mRNA

NCBI chr 3:134,300,628...134,318,704
Ensembl chr 3:134,300,632...134,318,711

G

hedgehog acyltransferase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HHAT mRNA

NCBI chr13:104,024,507...104,283,580
Ensembl chr13:106,541,866...106,811,563

G

hematopoietically expressed homeobox

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HHEX mRNA

NCBI chr 1:244,602,945...244,608,532
Ensembl chr 1:244,602,825...244,608,604

G

hexokinase 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of HK2 mRNA

NCBI chr 4:116,792,258...116,841,275
Ensembl chr 4:116,792,258...116,841,275

G

3-hydroxy-3-methylglutaryl-CoA synthase 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HMGCS1 mRNA

NCBI chr 2:53,379,457...53,399,807
Ensembl chr 2:53,382,643...53,399,802

G

3-hydroxy-3-methylglutaryl-CoA synthase 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HMGCS2 mRNA

NCBI chr 2:188,564,348...188,590,872
Ensembl chr 2:188,547,767...188,592,242

G

heme oxygenase 1

increases expression
multiple interactions
decreases expression

ISO
EXP

monomethylarsonic acid results in increased expression of HMOX1 mRNA
[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of HMOX1 mRNA
monomethylarsonic acid results in decreased expression of HMOX1 mRNA

PMID:15345372 PMID:23192986 PMID:24091636

NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818

G

4-hydroxy-2-oxoglutarate aldolase 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HOGA1 mRNA

NCBI chr 1:240,856,991...240,884,243
Ensembl chr 1:250,806,255...250,833,869

G

hippocalcin

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of HPCA mRNA

NCBI chr 5:146,739,978...146,750,961
Ensembl chr 5:146,739,978...146,749,983

G

heparan sulfate-glucosamine 3-sulfotransferase 3B1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of HS3ST3B1 mRNA

NCBI chr10:49,060,693...49,093,185
Ensembl chr10:49,060,693...49,093,185

G

heat shock transcription factor 2 binding protein

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HSF2BP mRNA

NCBI chr20:10,035,562...10,123,059
Ensembl chr20:10,035,263...10,121,826

G

heat shock protein family A (Hsp70) member 1A

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of HSPA1A mRNA

NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,855,780...3,877,979

G

heat shock protein family A (Hsp70) member 1B

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of HSPA1B mRNA

NCBI chr20:3,859,756...3,863,800
Ensembl chr20:3,855,780...3,877,979

G

heat shock protein family A (Hsp70) member 8

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of HSPA8 mRNA

NCBI chr 8:50,080,514...50,084,376
Ensembl chr 8:50,080,199...50,084,372

G

heat shock protein family B (small) member 7

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HSPB7 mRNA

NCBI chr 5:159,010,759...159,014,245
Ensembl chr 5:159,010,629...159,014,243

G

heat shock protein family H (Hsp110) member 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of HSPH1 mRNA

NCBI chr12:10,427,368...10,446,602
Ensembl chr12:10,427,297...10,446,891

G

hydrogen voltage-gated channel 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HVCN1 mRNA

NCBI chr12:34,341,673...34,370,010
Ensembl chr12:40,001,498...40,042,020

G

intercellular adhesion molecule 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ICAM1 mRNA

NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617

G

inducible T-cell co-stimulator

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ICOS mRNA

NCBI chr 9:69,862,042...69,900,864
Ensembl chr 9:69,877,785...69,900,960

G

insulin-like growth factor 1 receptor

increases expression

EXP

monomethylarsonic acid results in increased expression of IGF1R mRNA

NCBI chr 1:130,959,787...131,248,664
Ensembl chr 1:130,959,997...131,248,664

G

insulin-like growth factor binding protein 1

increases expression

ISO

monomethylarsonic acid results in increased expression of IGFBP1 mRNA

NCBI chr14:86,261,277...86,266,344
Ensembl chr14:86,261,277...86,266,344

G

immunoglobulin heavy chain like 16

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of IGHV4-1 mRNA

NCBI chr 6:134,212,480...134,234,464

G

immunoglobulin kappa variable like, pseudogene 13

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IGKV1-133 mRNA

NCBI chr 4:96,968,574...96,969,477

G

IKAROS family zinc finger 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IKZF1 mRNA

NCBI chr14:90,468,696...90,556,522
Ensembl chr14:90,469,172...90,557,574

G

interleukin 10 receptor subunit alpha

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL10RA mRNA

NCBI chr 8:54,459,754...54,474,786
Ensembl chr 8:54,459,882...54,475,028

G

interleukin 13 receptor subunit alpha 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL13RA2 mRNA

NCBI chr X:115,814,620...115,886,080
Ensembl chr X:115,814,622...115,841,455

G

interleukin 20 receptor subunit beta

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL20RB mRNA

NCBI chr 8:109,858,108...109,896,066
Ensembl chr 8:109,854,012...109,889,363

G

interleukin 21 receptor

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL21R mRNA

NCBI chr 1:189,598,682...189,626,340
Ensembl chr 1:189,598,558...189,626,342

G

interleukin 22 receptor subunit alpha 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL22RA2 mRNA

NCBI chr 1:16,172,238...16,228,009
Ensembl chr 1:16,184,113...16,197,950

G

interleukin 27 receptor subunit alpha

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL27RA mRNA

NCBI chr19:41,014,730...41,026,740
Ensembl chr19:41,014,730...41,026,760

G

interleukin 36, beta

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL36B mRNA

NCBI chr 3:27,422,980...27,521,344
Ensembl chr 3:27,423,171...27,428,678

G

interleukin 5 receptor subunit alpha

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL5RA mRNA

NCBI chr 4:141,186,749...141,221,348
Ensembl chr 4:141,171,158...141,220,943

G

interleukin 7 receptor

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL7R mRNA

NCBI chr 2:60,179,561...60,204,937
Ensembl chr 2:60,181,382...60,211,027

G

interleukin 9 receptor

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL9R mRNA

NCBI chr10:15,936,156...15,947,613
Ensembl chr10:15,936,156...15,947,613

G

insulin 1

multiple interactions

ISO

monomethylarsonic acid inhibits the reaction [INS1 protein results in increased uptake of Glucose]

NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:261,186,119...261,186,682

G

insulin induced gene 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of INSIG1 mRNA

NCBI chr 4:8,049,339...8,057,812
Ensembl chr 4:8,049,556...8,057,778

G

interferon regulatory factor 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IRF4 mRNA

NCBI chr17:33,930,460...33,948,842
Ensembl chr17:33,930,471...33,948,730

G

integrin subunit alpha 10

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ITGA10 mRNA

NCBI chr 2:186,871,711...186,891,012
Ensembl chr 2:186,871,711...186,891,012

G

integrin subunit alpha 8

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ITGA8 mRNA

NCBI chr17:80,213,139...80,410,633
Ensembl chr17:80,213,143...80,410,633

G

integrin subunit alpha L

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ITGAL mRNA

NCBI chr 1:191,348,424...191,386,228
Ensembl chr 1:191,348,542...191,386,225

G

integrin subunit beta 8

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ITGB8 mRNA

NCBI chr 6:140,125,002...140,208,261
Ensembl chr 6:146,165,484...146,351,245

G

inter-alpha trypsin inhibitor, heavy chain 3

increases expression

EXP

monomethylarsonic acid results in increased expression of ITIH3 mRNA

NCBI chr16:6,101,922...6,117,154
Ensembl chr16:6,108,382...6,123,374

G

ITPRIP like 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ITPRIPL2 mRNA

NCBI chr 1:172,801,152...172,803,047
Ensembl chr 1:182,231,093...182,245,858

G

IZUMO1 receptor, JUNO

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IZUMO1R mRNA

NCBI chr 8:11,744,384...11,748,131
Ensembl chr 8:20,025,831...20,029,578

G

junction mediating and regulatory protein, p53 cofactor

increases expression

ISO

monomethylarsonic acid results in increased expression of JMY mRNA

NCBI chr 2:24,662,104...24,730,955
Ensembl chr 2:26,409,969...26,465,649

G

Jun proto-oncogene, AP-1 transcription factor subunit

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of JUN mRNA

NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285

G

potassium voltage-gated channel modifier subfamily G member 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KCNG1 mRNA

NCBI chr 3:156,960,717...156,992,877
Ensembl chr 3:177,392,031...177,411,507

G

potassium voltage-gated channel interacting protein 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KCNIP4 mRNA

NCBI chr14:61,380,699...62,531,399
Ensembl chr14:65,593,366...66,743,993

G

potassium inwardly-rectifying channel, subfamily J, member 13

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of KCNJ13 mRNA

NCBI chr 9:95,509,228...95,528,400
Ensembl chr 9:95,510,877...95,520,817

G

potassium two pore domain channel subfamily K member 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of KCNK6 mRNA

NCBI chr 1:93,652,888...93,661,419

G

kelch-like family member 30

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KLHL30 mRNA

NCBI chr 9:91,942,475...91,952,756
Ensembl chr 9:99,390,014...99,400,295

G

kelch-like family member 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KLHL6 mRNA

NCBI chr11:94,475,262...94,514,653
Ensembl chr11:94,475,262...94,514,623

G

killer cell lectin like receptor B1A

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KLRB1 mRNA

NCBI chr 4:161,890,577...161,904,050
Ensembl chr 4:163,576,672...163,619,374

G

kynurenine 3-monooxygenase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KMO mRNA

NCBI chr13:90,089,340...90,121,108
Ensembl chr13:90,089,463...90,125,151

G

keratin 12

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KRT12 mRNA

NCBI chr10:84,370,803...84,378,103
Ensembl chr10:84,866,965...84,874,265

G

keratin 17

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KRT17 mRNA

NCBI chr10:85,178,673...85,183,392
Ensembl chr10:85,679,070...85,683,787

G

keratin 18

decreases expression

EXP

monomethylarsonic acid results in decreased expression of KRT18 mRNA

NCBI chr 7:135,036,168...135,039,844
Ensembl chr 7:135,035,982...135,039,848
Ensembl chr10:135,035,982...135,039,848

G

keratin 27

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KRT27 mRNA

NCBI chr10:84,298,684...84,303,967
Ensembl chr10:84,794,684...84,800,131

G

L3MBTL histone methyl-lysine binding protein 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of L3MBTL3 mRNA

NCBI chr 1:20,807,679...20,908,609
Ensembl chr 1:20,808,973...20,908,608

G

ladinin 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LAD1 mRNA

NCBI chr13:49,801,347...49,815,709
Ensembl chr13:49,800,472...49,815,709

G

leucyl-tRNA synthetase 2, mitochondrial

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LARS2 mRNA

NCBI chr 8:131,887,728...131,983,866
Ensembl chr 8:131,887,753...131,983,866

G

lymphocyte transmembrane adaptor 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LAX1 mRNA

NCBI chr13:47,686,840...47,697,396
Ensembl chr13:47,686,849...47,697,460

G

lymphocyte cytosolic protein 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LCP1 mRNA

NCBI chr15:56,846,375...56,954,090
Ensembl chr15:56,847,433...56,954,092

G

low density lipoprotein receptor

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LDLR mRNA

NCBI chr 8:28,546,191...28,569,075
Ensembl chr 8:28,546,146...28,570,675

G

lymphoid enhancer binding factor 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LEF1 mRNA

NCBI chr 2:222,340,541...222,453,931
Ensembl chr 2:222,340,704...222,453,929

G

galectin 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LGALS2 mRNA

NCBI chr 7:112,283,630...112,290,228
Ensembl chr 7:112,282,822...112,285,392

G

galectin 8

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of LGALS8 mRNA

NCBI chr17:62,716,368...62,744,272
Ensembl chr17:62,719,828...62,744,482

G

LHFPL tetraspan subfamily member 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of LHFPL2 mRNA

NCBI chr 2:27,016,404...27,169,830
Ensembl chr 2:27,016,700...27,162,859

G

lipase C, hepatic type

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LIPC mRNA

NCBI chr 8:80,390,470...80,516,463
Ensembl chr 8:80,390,471...80,516,285

G

lysophosphatidylcholine acyltransferase 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of LPCAT4 mRNA

NCBI chr 3:119,499,128...119,507,275
Ensembl chr 3:119,499,128...119,507,362

G

leupaxin

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LPXN mRNA

NCBI chr 1:219,353,319...219,387,743
Ensembl chr 1:219,353,708...219,387,742

G

leucine rich repeat containing 31

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LRRC31 mRNA

NCBI chr 2:112,702,844...112,725,431
Ensembl chr 2:114,631,136...114,652,269

G

leucine-rich repeat kinase 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LRRK2 mRNA

NCBI chr 7:124,706,246...124,867,234
Ensembl chr 7:124,706,080...124,867,239

G

lanosterol synthase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LSS mRNA

NCBI chr20:12,090,641...12,118,230
Ensembl chr20:12,073,543...12,118,253

G

lymphotoxin alpha

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LTA mRNA

NCBI chr20:3,622,291...3,625,852
Ensembl chr20:3,623,527...3,625,533

G

lymphotoxin beta

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LTB mRNA

NCBI chr20:3,632,209...3,634,054
Ensembl chr20:3,632,210...3,634,054

G

leukotriene B4 receptor 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LTB4R2 mRNA

NCBI chr15:29,258,712...29,260,531
Ensembl chr15:33,228,634...33,230,453

G

lymphocyte antigen 6 family member D

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LY6D mRNA

NCBI chr 7:106,643,225...106,644,733
Ensembl chr 7:108,532,215...108,533,716

G

lymphocyte antigen 6 family member G6C

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of LY6G6C mRNA

NCBI chr20:3,758,290...3,760,987
Ensembl chr20:3,758,290...3,762,927

G

lymphocyte antigen 9

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LY9 mRNA

NCBI chr13:86,610,762...86,633,314
Ensembl chr13:86,611,784...86,657,293

G

LYL1, basic helix-loop-helix family member

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LYL1 mRNA

NCBI chr19:40,356,967...40,359,834
Ensembl chr19:40,354,819...40,359,834

G

mitogen-activated protein kinase kinase kinase 19

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MAP3K19 mRNA

NCBI chr13:39,300,150...39,343,502
Ensembl chr13:41,852,531...41,895,565

G

mitogen-activated protein kinase kinase kinase 9

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MAP3K9 mRNA

NCBI chr 6:101,423,754...101,488,822
Ensembl chr 6:107,161,534...107,220,061

G

mitogen activated protein kinase kinase kinase kinase 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MAP4K1 mRNA

NCBI chr 1:84,270,951...84,292,496
Ensembl chr 1:93,398,454...93,419,993

G

mitogen activated protein kinase 1

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of MAPK1 mRNA

NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825

G

mitogen-activated protein kinase 15

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of MAPK15 mRNA

NCBI chr 7:109,575,619...109,595,339
Ensembl chr 7:109,575,561...109,595,346

G

melanin-concentrating hormone receptor 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of MCHR1 mRNA

NCBI chr 7:112,761,554...112,764,746
Ensembl chr 7:114,641,580...114,644,919

G

MDM2 proto-oncogene

increases expression
multiple interactions

EXP
ISO

monomethylarsonic acid results in increased expression of MDM2 mRNA
[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of MDM2 mRNA

PMID:17481689 PMID:23192986

NCBI chr 7:55,176,558...55,201,757
Ensembl chr 7:55,176,560...55,200,791

G

myocyte enhancer factor 2C

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MEF2C mRNA

NCBI chr 2:15,708,732...15,871,639
Ensembl chr 2:15,708,924...15,871,640

G

meiosis specific with coiled-coil domain

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MEIOC mRNA

NCBI chr10:88,128,939...88,147,833
Ensembl chr10:88,128,990...88,147,829

G

milk fat globule EGF and factor V/VIII domain containing

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MFGE8 mRNA

NCBI chr 1:142,474,027...142,489,431
Ensembl chr 1:142,474,028...142,489,431

G

major facilitator superfamily domain containing 12

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of MFSD12 mRNA

NCBI chr 7:8,998,050...9,004,724
Ensembl chr 7:8,998,050...9,004,724

G

MFSD2 lysolipid transporter B, sphingolipid

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of MFSD2B mRNA

NCBI chr 6:33,589,623...33,602,477
Ensembl chr 6:33,589,852...33,601,626

G

microRNA 145

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of MIR145A mRNA

NCBI chr18:57,369,983...57,370,070

G

Mir155 host gene

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MIR155HG mRNA

NCBI chr11:23,773,468...23,775,697

G

microRNA 192

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of MIR192 mRNA

NCBI chr 1:203,564,946...203,565,055
Ensembl chr 1:212,994,209...212,994,318

G

mohawk homeobox

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of MKX mRNA

NCBI chr17:59,772,113...59,851,160
Ensembl chr17:59,773,570...59,850,345

G

mixed lineage kinase domain like pseudokinase

increases phosphorylation

ISO

monomethylarsonic acid results in increased phosphorylation of MLKL protein

NCBI chr19:56,186,860...56,213,886
Ensembl chr19:56,186,860...56,213,858

G

maestro heat-like repeat family member 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of MROH6 mRNA

NCBI chr 7:107,566,212...107,576,469
Ensembl chr 7:109,449,268...109,455,087

G

maestro heat-like repeat family member 7

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of MROH7 mRNA

NCBI chr 5:121,463,826...121,509,233
Ensembl chr 5:126,692,649...126,731,161

G

membrane spanning 4-domains A1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MS4A1 mRNA

NCBI chr 1:217,331,274...217,351,934
Ensembl chr 1:217,331,274...217,343,447

G

membrane spanning 4-domains A18

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MS4A18 mRNA

NCBI chr 1:207,644,858...207,662,471
Ensembl chr 1:217,069,884...217,090,754

G

mutS homolog 2

decreases expression

EXP

monomethylarsonic acid results in decreased expression of MSH2 mRNA

NCBI chr 6:12,567,368...12,626,534
Ensembl chr 6:12,567,368...12,626,503

G

misato mitochondrial distribution and morphology regulator 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MSTO1 mRNA

NCBI chr 2:176,603,755...176,608,037
Ensembl chr 2:176,599,671...176,608,026

G

metallothionein 1, pseudogene 3

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of MT1E mRNA

NCBI chr17:79,695,812...79,696,200
Ensembl chr17:79,695,809...79,696,200

G

metallothionein 1A

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MT1 mRNA

NCBI chr19:10,831,959...10,832,975
Ensembl chr17:79,695,809...79,696,200
Ensembl chr X:79,695,809...79,696,200
Ensembl chr19:79,695,809...79,696,200

G

metallothionein 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MT4 mRNA

NCBI chr19:10,863,813...10,865,909
Ensembl chr19:10,869,735...10,871,831

G

mevalonate diphosphate decarboxylase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MVD mRNA

NCBI chr19:67,404,911...67,414,974
Ensembl chr19:67,404,911...67,422,366

G

mevalonate kinase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MVK mRNA

NCBI chr12:47,802,002...47,819,503
Ensembl chr12:47,802,002...47,819,503

G

MX dynamin like GTPase 1

multiple interactions

ISO

[Arsenic results in increased abundance of monomethylarsonic acid] which affects the expression of MX1 mRNA
[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of MX1 mRNA

PMID:28793237 PMID:34876320

NCBI chr11:50,269,056...50,294,699
Ensembl chr11:50,269,057...50,292,904

G

Max dimerization protein 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MXD3 mRNA

NCBI chr17:9,306,552...9,310,278
Ensembl chr17:9,302,321...9,310,278

G

MYB proto-oncogene, transcription factor

decreases expression

ISO

monomethylarsonic acid results in decreased expression of MYB mRNA

NCBI chr 1:17,759,309...17,793,306
Ensembl chr 1:17,759,309...17,792,547

G

MYB proto-oncogene like 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MYBL1 mRNA

NCBI chr 5:14,365,768...14,401,012
Ensembl chr 5:14,365,768...14,399,588

G

MYC proto-oncogene, bHLH transcription factor

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of MYC mRNA

NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028

G

myosin IG

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MYO1G mRNA

NCBI chr14:81,386,701...81,401,843
Ensembl chr14:85,600,619...85,615,760

G

myotilin

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of MYOT mRNA

NCBI chr18:36,956,119...36,975,728
Ensembl chr18:36,956,191...36,976,265

G

marginal zone B and B1 cell-specific protein

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MZB1 mRNA

NCBI chr18:27,238,999...27,241,060
Ensembl chr18:27,513,089...27,515,182

G

N-6 adenine-specific DNA methyltransferase 1

increases abundance

ISO

HEMK2 gene polymorphism results in increased abundance of monomethylarsonic acid

NCBI chr11:40,071,017...40,083,463
Ensembl chr11:40,070,993...40,083,680

G

N(alpha)-acetyltransferase 80, NatH catalytic subunit

decreases expression

ISO

monomethylarsonic acid results in decreased expression of NAA80 mRNA

NCBI chr 8:117,132,957...117,136,207
Ensembl chr 8:117,133,494...117,136,207

G

N-acetylated alpha-linked acidic dipeptidase-like 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NAALADL1 mRNA

NCBI chr 1:212,829,917...212,843,474
Ensembl chr 1:212,829,916...212,843,474

G

napsin A aspartic peptidase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NAPSA mRNA

NCBI chr 1:95,064,726...95,077,101
Ensembl chr 1:104,200,960...104,213,608

G

neutrophil cytosolic factor 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NCF1 mRNA

NCBI chr12:28,121,816...28,131,080
Ensembl chr12:28,121,366...28,131,079

G

neutrophil cytosolic factor 2

increases expression

ISO

monomethylarsonic acid results in increased expression of NCF2 mRNA

NCBI chr13:67,505,492...67,536,015
Ensembl chr13:67,505,375...67,536,149

G

noncompact myelin associated protein

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NCMAP mRNA

NCBI chr 5:152,893,173...152,921,175
Ensembl chr 5:152,894,316...152,902,414

G

N-myc downstream regulated 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NDRG1 mRNA

NCBI chr 7:100,573,526...100,614,902
Ensembl chr 7:100,573,523...100,614,913

G

N-deacetylase and N-sulfotransferase 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NDST3 mRNA

NCBI chr 2:211,702,728...211,868,159
Ensembl chr 2:214,389,447...214,539,164

G

nuclear paraspeckle assembly transcript 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of NEAT1 mRNA

NCBI chr 1:203,129,229...203,140,014

G

nebulin

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NEB mRNA

NCBI chr 3:57,022,822...57,220,752
Ensembl chr 3:57,022,822...57,220,709

G

nectin cell adhesion molecule 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NECTIN1 mRNA

NCBI chr 8:52,998,662...53,061,745
Ensembl chr 8:52,998,662...53,086,664

G

NFE2 like bZIP transcription factor 1

multiple interactions

ISO

[NFE2L1 protein alternative form results in decreased methylation of arsenite] which results in decreased abundance of monomethylarsonic acid

NCBI chr10:82,296,824...82,309,472
Ensembl chr10:82,292,508...82,309,375

G

NFE2 like bZIP transcription factor 2

decreases expression
decreases phosphorylation
multiple interactions

ISO

monomethylarsonic acid results in decreased expression of NFE2L2 mRNA
monomethylarsonic acid results in decreased phosphorylation of NFE2L2 protein
monomethylarsonic acid results in increased expression of and affects the localization of NFE2L2 protein; NFE2L2 mutant form inhibits the reaction [monomethylarsonic acid results in increased expression of NQO1 protein]

PMID:24091636 PMID:24161444 PMID:38630284

NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090

G

nuclear factor, interleukin 3 regulated

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of NFIL3 mRNA

NCBI chr17:12,432,376...12,447,605
Ensembl chr17:12,432,198...12,450,826

G

nuclear factor kappa B subunit 1

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of NFKB1 mRNA

NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:226,689,745...226,783,088

G

niban apoptosis regulator 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of NIBAN3 mRNA

NCBI chr16:18,307,122...18,318,589
Ensembl chr16:18,341,141...18,352,575

G

NIPA-like domain containing 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NIPAL4 mRNA

NCBI chr10:31,085,267...31,101,979
Ensembl chr10:31,085,267...31,101,979

G

NLR family, pyrin domain containing 9

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of NLRP9B mRNA

NCBI chr 1:77,320,034...77,370,366
Ensembl chr 1:77,319,218...77,378,658

G

neuromedin U

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NMU mRNA

NCBI chr14:32,198,789...32,226,397
Ensembl chr14:32,198,943...32,226,632

G

nocturnin

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of NOCT mRNA

NCBI chr 2:137,422,074...137,442,282
Ensembl chr 2:137,422,074...137,442,282

G

Nodal modulator 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NOMO1 mRNA

NCBI chr 1:105,641,867...105,692,708
Ensembl chr 1:105,641,879...105,692,707

G

neuronal PAS domain protein 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of NPAS4 mRNA

NCBI chr 1:211,710,640...211,728,038
Ensembl chr 1:211,711,338...211,716,102

G

neuropeptide FF receptor 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NPFFR1 mRNA

NCBI chr20:29,539,795...29,573,951
Ensembl chr20:30,082,604...30,114,998

G

NAD(P)H quinone dehydrogenase 1

multiple interactions
increases expression

ISO

monomethylarsonic acid promotes the reaction [sulforaphane results in increased expression of and results in increased activity of NQO1 protein]; monomethylarsonic acid promotes the reaction [sulforaphane results in increased expression of NQO1 mRNA]; monomethylarsonic acid promotes the reaction [Tetrachlorodibenzodioxin results in increased activity of NQO1 protein]; monomethylarsonic acid promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA]; monomethylarsonic acid results in increased expression of and results in increased activity of NQO1 protein; NFE2L2 mutant form inhibits the reaction [monomethylarsonic acid results in increased expression of NQO1 protein]
monomethylarsonic acid results in increased expression of NQO1 mRNA

NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260

G

nuclear receptor subfamily 0, group B, member 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of NR0B2 mRNA

NCBI chr 5:151,063,160...151,066,475
Ensembl chr 5:151,063,160...151,066,475

G

5' nucleotidase, ecto

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of NT5E mRNA

NCBI chr 8:98,150,925...98,195,646
Ensembl chr 8:98,150,900...98,195,645

G

nuclear GTPase, germinal center associated

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NUGGC mRNA

NCBI chr15:43,997,446...44,041,716
Ensembl chr15:43,997,438...44,041,643

G

neurexophilin and PC-esterase domain family, member 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NXPE3 mRNA

NCBI chr11:44,726,905...44,777,694
Ensembl chr11:58,195,976...58,248,644

G

neurexophilin and PC-esterase domain family member 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of NXPE4 mRNA

NCBI chr 8:48,502,697...48,744,101
Ensembl chr 8:57,631,895...57,644,186

G

nyctalopin

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of NYX mRNA

NCBI chr X:11,953,680...11,974,716
Ensembl chr X:11,953,018...11,974,810

G

2'-5' oligoadenylate synthetase 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of OAS2 mRNA

NCBI chr12:41,464,568...41,492,036
Ensembl chr12:41,467,315...41,495,881

G

8-oxoguanine DNA glycosylase

increases expression

EXP

monomethylarsonic acid results in increased expression of OGG1 mRNA

NCBI chr 4:148,030,237...148,037,599
Ensembl chr 4:148,030,349...148,037,604

G

olfactory receptor family 10 subfamily J member 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of OR10J2 mRNA

NCBI chr13:88,255,644...88,256,634
Ensembl chr13:88,255,644...88,256,634

G

odd-skipped related transcription factor 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of OSR2 mRNA

NCBI chr 7:68,372,500...68,380,195
Ensembl chr 7:68,373,049...68,380,805

G

3-oxoacid CoA transferase 2A

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of OXCT2A mRNA

NCBI chr 5:135,600,812...135,602,570
Ensembl chr 5:140,874,503...140,902,881

G

P2Y receptor family member 10

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of P2RY10 mRNA

NCBI chr X:72,121,558...72,207,174
Ensembl chr X:76,184,001...76,280,953

G

purinergic receptor P2Y2

decreases expression

ISO

monomethylarsonic acid results in decreased expression of P2RY2 mRNA

NCBI chr 1:164,764,119...164,779,578
Ensembl chr 1:164,759,213...164,781,852

G

prolyl 4-hydroxylase subunit alpha 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of P4HA1 mRNA

NCBI chr20:27,302,046...27,352,098
Ensembl chr20:27,845,141...27,895,404

G

parvin, gamma

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PARVG mRNA

NCBI chr 7:117,336,160...117,366,341
Ensembl chr 7:117,336,187...117,362,155

G

paired box 5

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PAX5 mRNA

NCBI chr 5:63,554,784...63,741,380
Ensembl chr 5:63,560,722...63,739,987

G

paired box 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PAX6 mRNA

NCBI chr 3:112,590,034...112,611,771
Ensembl chr 3:112,590,391...112,611,763

G

phosphatidylethanolamine binding protein 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PBP2 mRNA

NCBI chr 4:168,155,827...168,157,121
Ensembl chr 4:169,856,292...169,889,596

G

protocadherin related 15

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PCDH15 mRNA

NCBI chr20:13,996,383...15,495,206
Ensembl chr20:13,999,116...15,493,958

G

protocadherin gamma subfamily B, 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PCDHGB1 mRNA

NCBI chr18:29,501,739...29,508,024

G

PC-esterase domain containing 1B

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PCED1B mRNA

NCBI chr 7:128,394,388...128,528,231
Ensembl chr 7:130,270,554...130,410,365

G

proliferating cell nuclear antigen

increases expression

EXP

monomethylarsonic acid results in increased expression of PCNA mRNA

NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901

G

proprotein convertase subtilisin/kexin type 9

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PCSK9 mRNA

NCBI chr 5:126,440,102...126,462,507
Ensembl chr 5:126,440,102...126,462,507

G

pleckstrin homology-like domain, family A, member 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PHLDA1 mRNA

NCBI chr 7:48,853,690...48,855,894
Ensembl chr 7:48,853,260...48,857,542

G

polymeric immunoglobulin receptor

decreases expression

ISO

monomethylarsonic acid results in decreased expression of PIGR mRNA

NCBI chr13:44,851,001...44,879,143
Ensembl chr13:44,851,182...44,879,141

G

paired-like homeodomain 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PITX1 mRNA

NCBI chr17:8,794,134...8,800,292
Ensembl chr17:8,799,319...8,805,476

G

phospholipase A2 group IIA

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PLA2G2A mRNA

NCBI chr 5:156,359,725...156,362,302
Ensembl chr 5:156,359,725...156,362,297

G

phospholipase A2, group IID

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PLA2G2D mRNA

NCBI chr 5:156,299,374...156,305,816
Ensembl chr 5:156,297,777...156,305,812

G

phospholipase A2, group IVF

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PLA2G4F mRNA

NCBI chr 3:127,702,603...127,720,429
Ensembl chr 3:127,703,841...127,718,348

G

plasminogen activator, urokinase receptor

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PLAUR mRNA

NCBI chr 1:89,181,363...89,196,308
Ensembl chr 1:89,178,453...89,198,130

G

phospholipase B1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PLB1 mRNA

NCBI chr 6:24,087,051...24,227,167
Ensembl chr 6:29,809,290...29,930,183

G

phospholipase D family, member 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PLD4 mRNA

NCBI chr 6:137,639,948...137,647,462
Ensembl chr 6:137,639,945...137,649,024

G

pleckstrin

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PLEK mRNA

NCBI chr14:95,598,650...95,631,326
Ensembl chr14:95,598,654...95,655,721

G

pleckstrin homology and RhoGEF domain containing G4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PLEKHG4 mRNA

NCBI chr19:50,161,722...50,176,491
Ensembl chr19:50,159,754...50,182,133

G

placenta expressed transcript 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PLET1 mRNA

NCBI chr 8:50,842,242...50,853,666
Ensembl chr 8:59,738,529...59,750,406

G

polo-like kinase 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PLK3 mRNA

NCBI chr 5:135,843,725...135,848,900
Ensembl chr 5:135,843,725...135,848,900

G

plexin C1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PLXNC1 mRNA

NCBI chr 7:31,276,978...31,430,823
Ensembl chr 7:31,276,978...31,431,092

G

phorbol-12-myristate-13-acetate-induced protein 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PMAIP1 mRNA

NCBI chr18:62,255,970...62,262,384
Ensembl chr18:62,255,598...62,262,382

G

patatin-like phospholipase domain containing 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PNPLA1 mRNA

NCBI chr20:6,919,689...6,953,850
Ensembl chr20:6,919,115...6,955,143

G

patatin-like phospholipase domain containing 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PNPLA3 mRNA

NCBI chr 7:117,173,485...117,194,065
Ensembl chr 7:117,173,516...117,194,594

G

POU class 2 homeobox associating factor 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of POU2AF1 mRNA

NCBI chr 8:60,418,173...60,445,176
Ensembl chr 8:60,436,844...60,445,176

G

POU class 2 homeobox 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of POU2F2 mRNA

NCBI chr 1:89,810,153...89,897,560
Ensembl chr 1:89,812,093...89,897,564

G

protein phosphatase 1, regulatory subunit 12B

decreases expression

ISO

monomethylarsonic acid results in decreased expression of PPP1R12B mRNA

NCBI chr13:48,751,256...48,948,933
Ensembl chr13:48,751,477...48,948,922

G

protein phosphatase 1, regulatory subunit 16B

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PPP1R16B mRNA

NCBI chr 3:147,323,652...147,419,658
Ensembl chr 3:167,743,952...167,839,242

G

PRAME like 34

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PRAMEL34 mRNA

NCBI chr14:13,850,057...13,852,806
Ensembl chr14:14,153,477...14,156,758

G

protein kinase C, alpha

increases expression

EXP

monomethylarsonic acid results in increased expression of PRKCA mRNA

NCBI chr10:93,388,991...93,787,617
Ensembl chr10:93,388,991...93,787,572

G

proline rich 5 like

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PRR5L mRNA

NCBI chr 3:88,001,951...88,173,532
Ensembl chr 3:108,458,633...108,537,763

G

serine protease 16

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PRSS16 mRNA

NCBI chr17:42,514,306...42,521,885
Ensembl chr17:47,210,081...47,217,658

G

phosphatase and tensin homolog

decreases expression

ISO
EXP

monomethylarsonic acid results in decreased expression of PTEN mRNA

NCBI chr 1:240,043,707...240,110,330
Ensembl chr 1:240,043,707...240,110,330

G

prostaglandin F receptor

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PTGFR mRNA

NCBI chr 2:240,731,185...240,766,674
Ensembl chr 2:243,393,350...243,425,623

G

protein tyrosine phosphatase, non-receptor type 7

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PTPN7 mRNA

NCBI chr13:49,122,679...49,136,096
Ensembl chr13:49,122,609...49,136,094

G

protein tyrosine phosphatase, receptor type, C

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PTPRC mRNA

NCBI chr13:52,147,717...52,259,810
Ensembl chr13:52,147,717...52,259,746

G

protein tyrosine phosphatase, receptor type, C-associated protein

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PTPRCAP mRNA

NCBI chr 1:201,449,133...201,451,293
Ensembl chr 1:210,878,573...210,881,753

G

pyroglutamylated RFamide peptide receptor

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of QRFPR mRNA

NCBI chr 2:119,053,083...119,096,864
Ensembl chr 2:120,981,235...121,025,020

G

RAB33A, member RAS oncogene family

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RAB33A mRNA

NCBI chr X:127,694,219...127,706,378
Ensembl chr X:132,572,148...132,584,254

G

RAD51 paralog C

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RAD51C mRNA

NCBI chr10:72,702,299...72,728,980
Ensembl chr10:72,702,299...72,729,143

G

RPA1 related single stranded DNA binding protein, X-linked

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RADX mRNA

NCBI chr X:107,877,835...107,965,476
Ensembl chr X:107,877,920...107,965,476

G

Raf-1 proto-oncogene, serine/threonine kinase

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of RAF1 mRNA

NCBI chr 4:150,352,158...150,412,813
Ensembl chr 4:150,352,160...150,412,813

G

ral guanine nucleotide dissociation stimulator like 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RGL3 mRNA

NCBI chr 8:20,500,846...20,520,471
Ensembl chr 8:28,776,909...28,796,771

G

Rap guanine nucleotide exchange factor like 1

decreases expression

ISO

monomethylarsonic acid results in decreased expression of RAPGEFL1 mRNA

NCBI chr10:83,793,711...83,810,373
Ensembl chr10:84,289,980...84,306,614

G

RAS protein activator like 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RASAL3 mRNA

NCBI chr 7:11,396,554...11,411,347
Ensembl chr 7:12,047,090...12,061,883

G

ras related dexamethasone induced 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RASD1 mRNA

NCBI chr10:45,265,975...45,275,279
Ensembl chr10:45,265,979...45,267,710

G

RAS guanyl releasing protein 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RASGRP3 mRNA

NCBI chr 6:25,647,386...25,745,952
Ensembl chr 6:25,647,386...25,710,591

G

RAS-like family 11 member A

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RASL11A mRNA

NCBI chr12:13,372,023...13,374,784
Ensembl chr12:13,372,023...13,376,451

G

REC114 meiotic recombination protein

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of REC114 mRNA

NCBI chr 8:59,063,352...59,221,439
Ensembl chr 8:67,958,421...68,119,234

G

REC8 meiotic recombination protein

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of REC8 mRNA

NCBI chr15:29,109,862...29,117,327
Ensembl chr15:33,079,801...33,087,282

G

receptor accessory protein 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of REEP6 mRNA

NCBI chr 7:10,024,601...10,031,507
Ensembl chr 7:10,024,602...10,031,740

G

regenerating family member 3 beta

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of REG3B mRNA

NCBI chr 4:112,419,776...112,423,014
Ensembl chr 4:112,419,776...112,423,014

G

regenerating family member 3 gamma

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of REG3G mRNA

NCBI chr 4:112,482,183...112,484,738
Ensembl chr 4:112,482,183...112,484,738

G

RELA proto-oncogene, NF-kB subunit

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of RELA mRNA

NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817

G

RELT-like 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RELL2 mRNA

NCBI chr18:29,789,996...29,793,986
Ensembl chr18:30,041,563...30,045,187

G

regulatory factor X-associated protein

decreases expression

ISO

monomethylarsonic acid results in decreased expression of RFXAP mRNA

NCBI chr 2:141,158,214...141,162,397
Ensembl chr 2:141,158,215...141,162,397

G

regulator of G-protein signaling 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RGS1 mRNA

NCBI chr13:58,568,844...58,573,187
Ensembl chr13:58,568,844...58,573,187

G

ras homolog family member H

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RHOH mRNA

NCBI chr14:42,694,860...42,725,690
Ensembl chr14:42,693,413...42,749,967

G

receptor-interacting serine-threonine kinase 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RIPK3 mRNA

NCBI chr15:33,253,071...33,262,025
Ensembl chr15:33,253,071...33,262,025

G

RHO family interacting cell polarization regulator 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RIPOR2 mRNA

NCBI chr17:40,751,771...40,975,611
Ensembl chr17:40,751,771...40,975,337

G

ribonuclease A family member 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RNASE6 mRNA

NCBI chr15:24,354,305...24,357,289
Ensembl chr15:26,827,009...26,830,825

G

ring finger protein 225

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RNF225 mRNA

NCBI chr 1:73,543,598...73,546,269
Ensembl chr 1:82,615,787...82,618,456

G

ring finger protein 24

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RNF24 mRNA

NCBI chr 3:118,520,459...118,575,213
Ensembl chr 3:138,973,492...139,028,177

G

ROS proto-oncogene 1 , receptor tyrosine kinase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ROS1 mRNA

NCBI chr20:31,975,328...32,126,675
Ensembl chr20:31,975,329...32,126,547

G

ribonuclease P RNA component H1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of RPPH1 mRNA

NCBI chr15:24,033,679...24,033,935
Ensembl chr15:26,507,215...26,507,512

G

ribosomal protein S6 kinase related

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RSKR mRNA

NCBI chr10:63,185,286...63,191,963
Ensembl chr10:63,683,479...63,687,889

G

RT1 class II, locus DOa

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of H2-OA mRNA

NCBI chr20:4,753,587...4,756,590
Ensembl chr20:4,755,499...4,758,478

G

RT1 class II, locus DOb

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of H2-OB mRNA

NCBI chr20:4,621,336...4,627,537
Ensembl chr20:4,619,694...4,627,523

G

rubicon like autophagy enhancer

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RUBCNL mRNA

NCBI chr15:50,332,458...50,377,494
Ensembl chr15:56,741,869...56,779,649

G

ryanodine receptor 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RYR1 mRNA

NCBI chr 1:93,420,078...93,551,305
Ensembl chr 1:93,420,078...93,551,305

G

ryanodine receptor 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RYR3 mRNA

NCBI chr 3:119,886,129...120,433,465
Ensembl chr 3:119,885,878...120,433,677

G

S100 calcium binding protein G

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of S100G mRNA

NCBI chr X:35,337,636...35,340,205
Ensembl chr X:35,337,675...35,340,205

G

sphingosine-1-phosphate receptor 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of S1PR4 mRNA

NCBI chr 7:8,207,767...8,210,043
Ensembl chr 7:8,858,904...8,860,800

G

sacsin molecular chaperone

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SACS mRNA

NCBI chr15:39,461,853...39,546,419
Ensembl chr15:39,472,905...39,546,419

G

sterile alpha motif domain containing 4A

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SAMD4 mRNA

NCBI chr15:22,616,200...22,831,872
Ensembl chr15:22,614,287...22,831,872

G

SAM domain, SH3 domain and nuclear localization signals, 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SAMSN1 mRNA

NCBI chr11:27,971,565...28,021,944
Ensembl chr11:27,970,564...28,021,944

G

SAM and SH3 domain containing 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SASH3 mRNA

NCBI chr X:132,204,717...132,219,421
Ensembl chr X:132,204,543...132,219,419

G

sciellin

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SCEL mRNA

NCBI chr15:80,339,661...80,456,546
Ensembl chr15:86,754,373...86,871,195

G

sodium voltage-gated channel alpha subunit 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SCN4A mRNA

NCBI chr10:91,745,459...91,796,452
Ensembl chr10:91,746,715...91,796,324

G

secreted and transmembrane 1B

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SECTM1A mRNA

NCBI chr10:106,822,397...106,832,105
Ensembl chr10:106,822,397...106,832,104

G

selectin L

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SELL mRNA

NCBI chr13:78,950,100...78,969,604
Ensembl chr13:78,950,015...78,969,600

G

semaphorin 7A (John Milton Hagen blood group)

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SEMA7A mRNA

NCBI chr 8:67,244,318...67,267,060
Ensembl chr 8:67,243,824...67,267,058

G

serpin family C member 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SERPINC1 mRNA

NCBI chr13:75,790,558...75,804,826
Ensembl chr13:75,790,546...75,817,643

G

serpin family F member 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SERPINF2 mRNA

NCBI chr10:60,770,698...60,778,782
Ensembl chr10:60,770,698...60,778,996

G

secreted frizzled-related protein 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SFRP4 mRNA

NCBI chr17:45,278,867...45,330,806
Ensembl chr17:50,015,812...50,026,395

G

serum/glucocorticoid regulated kinase 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SGK1 mRNA

NCBI chr 1:24,799,391...24,916,886
Ensembl chr 1:24,799,396...24,807,231

G

SH3 domain containing 21

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SH3D21 mRNA

NCBI chr 5:138,429,180...138,444,540
Ensembl chr 5:143,713,718...143,729,257

G

shroom family member 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SHROOM4 mRNA

NCBI chr X:18,537,371...18,748,665
Ensembl chr X:18,540,913...18,748,700

G

signaling lymphocytic activation molecule family member 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLAMF1 mRNA

NCBI chr13:86,802,708...86,837,890
Ensembl chr13:86,802,708...86,837,890

G

SLAM family member 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLAMF6 mRNA

NCBI chr13:86,916,956...86,937,697
Ensembl chr13:86,916,122...86,938,354

G

SLAM family member 7

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLAMF7 mRNA

NCBI chr13:86,668,060...86,688,222
Ensembl chr13:86,668,060...86,686,341

G

solute carrier family 10 member 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC10A1 mRNA

NCBI chr 6:106,344,319...106,357,944
Ensembl chr 6:106,344,319...106,357,944

G

solute carrier family 10 member 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC10A6 mRNA

NCBI chr14:6,385,348...6,407,532
Ensembl chr14:6,385,537...6,408,894

G

solute carrier family 13 member 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLC13A1 mRNA

NCBI chr 4:53,534,763...53,612,704
Ensembl chr 4:53,534,768...53,612,704

G

solute carrier family 14 member 1 (Kidd blood group)

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLC14A1 mRNA

NCBI chr18:71,565,453...71,608,807
Ensembl chr18:73,840,569...73,870,489

G

solute carrier family 15, member 5

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC15A5 mRNA

NCBI chr 4:172,609,293...172,702,893
Ensembl chr 4:172,608,999...172,702,893

G

solute carrier family 16 member 8

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC16A8 mRNA

NCBI chr 7:112,698,701...112,702,496
Ensembl chr 7:112,698,701...112,702,496

G

solute carrier family 26 member 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC26A2 mRNA

NCBI chr18:56,918,662...56,937,032
Ensembl chr18:56,923,337...56,937,012

G

solute carrier family 27 member 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC27A3 mRNA

NCBI chr 2:175,853,241...175,857,909
Ensembl chr 2:178,150,835...178,155,503

G

solute carrier family 28 member 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLC28A2 mRNA

NCBI chr 3:129,778,425...129,841,292
Ensembl chr 3:129,807,537...129,841,291

G

solute carrier family 28 member 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLC28A3 mRNA

NCBI chr17:6,068,034...6,120,421
Ensembl chr17:6,068,060...6,120,417

G

solute carrier family 29 member 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLC29A4 mRNA

NCBI chr12:16,967,047...16,998,276
Ensembl chr12:16,967,047...16,988,338

G

solute carrier family 2 member 1

increases import
decreases expression

ISO
EXP

SLC2A1 protein results in increased import of monomethylarsonic acid
monomethylarsonic acid results in decreased expression of SLC2A1 mRNA

PMID:17064664 PMID:38630284

NCBI chr 5:138,002,522...138,030,742
Ensembl chr 5:138,002,522...138,030,742

G

solute carrier family 2 member 5

multiple interactions
decreases expression

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLC2A5 mRNA
monomethylarsonic acid results in decreased expression of SLC2A5 mRNA

PMID:34876320 PMID:38630284

NCBI chr 5:165,857,412...165,892,928
Ensembl chr 5:165,866,172...165,894,038

G

solute carrier family 34 member 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC34A2 mRNA

NCBI chr14:62,123,313...62,153,020
Ensembl chr14:62,123,316...62,143,360

G

solute carrier family 38, member 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLC38A3 mRNA

NCBI chr 8:117,202,534...117,220,310
Ensembl chr 8:117,202,536...117,218,630

G

solute carrier family 38, member 8

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC38A8 mRNA

NCBI chr19:64,432,524...64,468,852
Ensembl chr19:64,437,013...64,463,960

G

solute carrier family 39 member 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC39A2 mRNA

NCBI chr15:24,590,738...24,592,850
Ensembl chr15:27,064,237...27,066,349

G

solute carrier family 41, member 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLC41A3 mRNA

NCBI chr 4:124,666,789...124,711,968
Ensembl chr 4:124,666,808...124,711,967

G

solute carrier family 5 member 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC5A3 mRNA

NCBI chr11:44,799,787...44,802,233
Ensembl chr11:44,790,297...44,818,157

G

solute carrier family 5 member 9

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLC5A9 mRNA

NCBI chr 5:131,937,368...131,966,405
Ensembl chr 5:131,938,216...131,961,922

G

solute carrier family 6 member 18

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC6A18 mRNA

NCBI chr 1:31,436,577...31,450,478
Ensembl chr 1:31,436,630...31,450,478

G

solute carrier family 7 member 9

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLC7A9 mRNA

NCBI chr 1:97,246,253...97,269,546
Ensembl chr 1:97,247,547...97,269,543

G

solute carrier family 8 member A3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLC8A3 mRNA

NCBI chr 6:106,605,611...106,739,208
Ensembl chr 6:106,605,621...106,721,412

G

solute carrier family 9 member A3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC9A3 mRNA

NCBI chr 1:30,953,215...30,996,209
Ensembl chr 1:30,953,216...30,996,002

G

solute carrier organic anion transporter family, member 5A1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLCO5A1 mRNA

NCBI chr 5:11,012,001...11,141,180
Ensembl chr 5:11,012,075...11,141,177

G

stannin

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SNN mRNA

NCBI chr10:4,572,933...4,581,606
Ensembl chr 1:82,440,586...82,441,390
Ensembl chr10:82,440,586...82,441,390

G

sterol O-acyltransferase 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SOAT2 mRNA

NCBI chr 7:133,281,818...133,294,915
Ensembl chr 7:135,160,402...135,173,513

G

superoxide dismutase 1

increases expression

ISO
EXP

monomethylarsonic acid results in increased expression of SOD1 mRNA

NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399

G

superoxide dismutase 2

increases expression

EXP
ISO

monomethylarsonic acid results in increased expression of SOD2 mRNA

NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168

G

SP100 nuclear antigen

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SP140 mRNA

NCBI chr 9:93,758,975...93,825,068
Ensembl chr 9:93,759,075...93,825,068

G

sperm associated antigen 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SPAG1 mRNA

NCBI chr 7:69,246,301...69,306,483
Ensembl chr 7:69,246,582...69,306,482

G

spermatogenesis associated 6-like

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SPATA6L mRNA

NCBI chr 1:236,042,960...236,096,530
Ensembl chr 1:236,033,147...236,096,730

G

spermatogenesis associated, serine-rich 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SPATS1 mRNA

NCBI chr 9:15,527,179...15,562,286
Ensembl chr 9:23,024,609...23,059,730

G

small proline-rich protein 1A

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SPRR1A mRNA

NCBI chr 2:178,055,096...178,057,012
Ensembl chr 2:180,750,709...180,752,991

G

small proline rich protein 2A

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SPRR2H mRNA

NCBI chr 2:177,815,964...177,816,236

G

sprouty RTK signaling antagonist 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SPRY4 mRNA

NCBI chr18:30,687,633...30,702,546
Ensembl chr18:30,687,039...30,704,173

G

serine palmitoyltransferase, small subunit B

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SPTSSB mRNA

NCBI chr 2:154,133,728...154,162,127
Ensembl chr 2:156,432,512...156,460,909

G

squalene epoxidase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SQLE mRNA

NCBI chr 7:92,758,175...92,773,049
Ensembl chr 7:92,757,409...92,773,050

G

SRC proto-oncogene, non-receptor tyrosine kinase

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of SRC mRNA

NCBI chr 3:166,511,616...166,559,463
Ensembl chr 3:166,511,985...166,559,462

G

sterol regulatory element binding transcription factor 1

decreases expression

ISO

monomethylarsonic acid results in decreased expression of SREBF1 mRNA

NCBI chr10:45,507,152...45,529,164
Ensembl chr10:45,507,152...45,529,164

G

sterol regulatory element binding transcription factor 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SREBF2 mRNA

NCBI chr 7:115,542,774...115,600,945
Ensembl chr 7:115,543,290...115,600,943

G

SRSF protein kinase 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SRPK3 mRNA

NCBI chr X:156,661,888...156,666,537
Ensembl chr X:156,661,875...156,666,531

G

ST3 beta-galactoside alpha-2,3-sialyltransferase 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ST3GAL4 mRNA

NCBI chr 8:41,673,510...41,723,158
Ensembl chr 8:41,673,510...41,712,551

G

ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ST6GALNAC3 mRNA

NCBI chr 2:242,129,755...242,645,120
Ensembl chr 2:244,789,627...245,304,977

G

ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ST8SIA4 mRNA

NCBI chr 9:103,437,479...103,532,008
Ensembl chr 9:103,437,479...103,532,008

G

ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ST8SIA6 mRNA

NCBI chr17:76,740,755...76,884,178
Ensembl chr17:81,653,687...81,792,732

G

signal transducing adaptor family member 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of STAP1 mRNA

NCBI chr14:22,301,278...22,336,218
Ensembl chr14:22,236,616...22,342,652

G

signal transducer and activator of transcription 3

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of STAT3 mRNA

NCBI chr10:86,311,528...86,363,513
Ensembl chr10:86,311,535...86,363,359

G

sushi domain containing 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SUSD3 mRNA

NCBI chr17:15,400,845...15,417,851
Ensembl chr17:15,606,906...15,624,262

G

synaptonemal complex protein 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SYCP2 mRNA

NCBI chr 3:185,814,033...185,876,516
Ensembl chr 3:185,814,035...185,876,492

G

synaptotagmin 5

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SYT5 mRNA

NCBI chr 1:69,277,351...69,285,071
Ensembl chr 1:78,320,034...78,327,746

G

synaptotagmin 8

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SYT8 mRNA

NCBI chr 1:197,588,126...197,593,598
Ensembl chr 1:207,017,461...207,023,076

G

TBC1 domain family, member 10C

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TBC1D10C mRNA

NCBI chr 1:201,476,258...201,484,876
Ensembl chr 1:210,906,616...210,994,356

G

transcription factor 23

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TCF23 mRNA

NCBI chr 6:25,397,889...25,406,639
Ensembl chr 6:31,120,127...31,125,878

G

transcription factor 24

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TCF24 mRNA

NCBI chr 5:9,274,659...9,282,876
Ensembl chr 5:14,058,039...14,063,345

G

t-complex protein 10b

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TCP10A mRNA

NCBI chr 1:52,937,823...52,961,307
Ensembl chr 1:55,485,411...55,508,836

G

terminal nucleotidyltransferase 5B

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TENT5B mRNA

NCBI chr 5:145,695,358...145,702,668
Ensembl chr11:27,212,316...27,214,238
Ensembl chr 5:27,212,316...27,214,238

G

transforming growth factor, beta 1

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of TGFB1 mRNA

NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899

G

transforming growth factor, beta receptor 2

increases expression

EXP

monomethylarsonic acid results in increased expression of TGFBR2 mRNA

NCBI chr 8:124,672,677...124,761,741
Ensembl chr 8:124,674,986...124,761,469

G

transglutaminase 7

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TGM7 mRNA

NCBI chr 3:108,051,890...108,068,116
Ensembl chr 3:128,505,650...128,529,939

G

thrombomodulin

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of THBD mRNA

NCBI chr 3:156,316,526...156,320,178
Ensembl chr 3:156,306,632...156,320,582

G

thrombospondin 2

decreases expression

ISO

monomethylarsonic acid results in decreased expression of THBS2 mRNA

NCBI chr 1:64,343,523...64,372,918
Ensembl chr 1:64,343,523...64,372,918

G

thymocyte selection associated

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of THEMIS mRNA

NCBI chr 1:16,433,906...16,623,889
Ensembl chr 1:18,272,056...18,483,502

G

TRAF-interacting protein with forkhead-associated domain

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TIFA mRNA

NCBI chr 2:218,927,724...218,942,111
Ensembl chr 2:218,909,915...218,956,224

G

toll-like receptor 8

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TLR8 mRNA

NCBI chr X:30,708,714...30,733,104
Ensembl chr X:30,708,033...30,737,079

G

toll-like receptor 9

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TLR9 mRNA

NCBI chr 8:115,743,407...115,747,523
Ensembl chr 8:115,742,889...115,750,148

G

transmembrane 4 L six family member 20

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TM4SF20 mRNA

NCBI chr 9:84,038,715...84,052,615
Ensembl chr 9:91,486,847...91,500,745

G

transmembrane p24 trafficking protein 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TMED6 mRNA

NCBI chr19:51,876,561...51,882,648
Ensembl chr19:51,876,561...51,882,648

G

transmembrane protein 140

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TMEM140 mRNA

NCBI chr 4:63,536,477...63,547,478
Ensembl chr 4:64,500,439...64,521,990

G

transmembrane protein 156

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TMEM156 mRNA

NCBI chr14:43,221,464...43,252,453
Ensembl chr14:43,577,023...43,606,109

G

transmembrane protein 17

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TMEM17 mRNA

NCBI chr14:100,684,655...100,725,471
Ensembl chr14:100,685,093...100,725,470

G

transmembrane protein 266

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TMEM266 mRNA

NCBI chr 8:55,707,122...55,820,692
Ensembl chr 8:64,603,186...64,716,769

G

transmembrane protein 71

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TMEM71 mRNA

NCBI chr 7:100,166,038...100,212,234
Ensembl chr 7:100,166,516...100,204,969

G

TNF receptor superfamily member 13B

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TNFRSF13B mRNA

NCBI chr10:46,301,336...46,322,460
Ensembl chr10:46,301,316...46,324,408

G

TNF receptor superfamily member 13C

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TNFRSF13C mRNA

NCBI chr 7:115,616,139...115,618,647
Ensembl chr 7:115,616,303...115,618,620

G

TNF receptor superfamily member 1A

decreases expression

EXP

monomethylarsonic acid results in decreased expression of TNFRSF1A mRNA

NCBI chr 4:159,837,119...159,849,817
Ensembl chr 4:159,837,032...159,849,816

G

TNF receptor superfamily member 25

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TNFRSF25 mRNA

NCBI chr 5:167,904,377...167,909,052
Ensembl chr 5:167,904,786...167,909,052

G

TNF superfamily member 11

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TNFSF11 mRNA

NCBI chr15:60,083,008...60,114,479
Ensembl chr15:60,083,008...60,114,479

G

TNF superfamily member 8

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TNFSF8 mRNA

NCBI chr 5:82,266,436...82,292,858
Ensembl chr 5:82,266,436...82,292,858

G

troponin I2, fast skeletal type

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TNNI2 mRNA

NCBI chr 1:206,882,358...207,027,034
Ensembl chr 1:207,024,416...207,027,038

G

troponin T3, fast skeletal type

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TNNT3 mRNA

NCBI chr 1:207,082,014...207,099,014
Ensembl chr 1:207,081,812...207,099,423

G

tumor protein p53

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of TP53 mRNA

NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299

G

tubulin polymerization promoting protein

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TPPP mRNA

NCBI chr 1:31,085,680...31,109,703
Ensembl chr 1:31,089,824...31,109,654

G

transformer 2 alpha

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TRA2A mRNA

NCBI chr 4:78,220,838...78,239,737
Ensembl chr 4:79,551,542...79,570,619

G

TNF receptor-associated factor 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TRAF1 mRNA

NCBI chr 3:38,607,707...38,639,641
Ensembl chr 3:38,619,506...38,636,264

G

Tnf receptor-associated factor 3

decreases expression

ISO

monomethylarsonic acid results in decreased expression of TRAF3 mRNA

NCBI chr 6:136,025,097...136,128,363
Ensembl chr 6:136,027,157...136,128,363

G

TRAF3 interacting protein 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TRAF3IP3 mRNA

NCBI chr13:104,694,802...104,719,655
Ensembl chr13:107,223,502...107,248,155

G

tetratricopeptide repeat and ankyrin repeat containing 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TRANK1 mRNA

NCBI chr 8:120,153,381...120,233,879
Ensembl chr 8:120,154,362...120,234,087

G

T cell receptor associated transmembrane adaptor 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TRAT1 mRNA

NCBI chr11:52,035,750...52,077,805
Ensembl chr11:65,498,742...65,542,381

G

tripartite motif containing 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TRIM6 mRNA

NCBI chr 1:168,095,619...168,108,809
Ensembl chr 1:168,095,564...168,109,719

G

transient receptor potential cation channel, subfamily C, member 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TRPC3 mRNA

NCBI chr 2:121,409,436...121,487,095
Ensembl chr 2:121,409,436...121,475,823

G

transient receptor potential cation channel, subfamily V, member 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TRPV3 mRNA

NCBI chr10:58,382,054...58,413,657
Ensembl chr10:58,382,054...58,411,800

G

transient receptor potential cation channel, subfamily V, member 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TRPV6 mRNA

NCBI chr 4:71,474,006...71,489,667
Ensembl chr 4:71,474,007...71,489,671

G

tetraspanin 32

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TSPAN32 mRNA

NCBI chr 1:198,190,128...198,204,447
Ensembl chr 1:207,619,567...207,656,946

G

tubulin tyrosine ligase like 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TTLL2 mRNA

NCBI chr 1:52,967,183...52,976,690
Ensembl chr 1:55,515,397...55,524,071

G

tubulin tyrosine ligase like 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TTLL3 mRNA

NCBI chr 4:146,532,958...146,558,425
Ensembl chr 4:148,089,575...148,113,499

G

tubulin tyrosine ligase like 9

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TTLL9 mRNA

NCBI chr 3:141,429,351...141,475,965
Ensembl chr 3:161,876,685...161,936,215

G

tweety family member 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TTYH3 mRNA

NCBI chr12:13,996,831...14,025,457
Ensembl chr12:19,110,824...19,139,371

G

TXK tyrosine kinase

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TXK mRNA

NCBI chr14:35,817,270...35,873,454
Ensembl chr14:35,817,893...35,873,460

G

thioredoxin 1

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of TXN mRNA

NCBI chr 5:77,507,455...77,519,685
Ensembl chr 5:77,507,321...77,520,307

G

thioredoxin reductase 1

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of TXNRD1 mRNA

NCBI chr 7:22,717,620...22,802,553
Ensembl chr 7:22,719,317...22,739,817

G

uncoupling protein 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of UCP2 mRNA

NCBI chr 1:164,251,373...164,257,742
Ensembl chr 1:164,251,373...164,257,743

G

UDP glucuronosyltransferase 1 family, polypeptide A2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of UGT1A2 mRNA

NCBI chr 9:96,239,019...96,256,264
Ensembl chr 9:96,144,786...96,256,264

G

UDP glucuronosyltransferase family 1 member A5

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of UGT1A5 mRNA

NCBI chr 9:96,210,053...96,256,264
Ensembl chr 9:96,144,786...96,256,264

G

UL16 binding protein 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ULBP1 mRNA

NCBI chr 1:1,694,255...1,716,160

G

vascular cell adhesion molecule 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of VCAM1 mRNA

NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:206,723,044...206,742,801

G

vascular endothelial growth factor A

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of VEGFA mRNA

NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194

G

vanin 1

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of VNN1 mRNA

NCBI chr 1:23,356,324...23,366,629
Ensembl chr 1:23,356,330...23,366,629

G

V-set pre-B cell surrogate light chain 3

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of VPREB3 mRNA

NCBI chr20:12,716,862...12,720,108

G

vacuolar protein sorting 25 homolog

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of VPS25 mRNA

NCBI chr10:86,696,330...86,701,871
Ensembl chr10:86,696,157...86,701,871

G

WASP actin nucleation promoting factor

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of WAS mRNA

NCBI chr X:17,077,057...17,085,802
Ensembl chr X:17,073,314...17,085,802

G

WDFY family member 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of WDFY4 mRNA

NCBI chr16:8,228,147...8,456,777
Ensembl chr16:8,228,147...8,456,761

G

WD repeat domain 31

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of WDR31 mRNA

NCBI chr 5:75,897,074...75,917,461
Ensembl chr 5:80,908,726...80,933,046

G

WD repeat domain 54

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of WDR54 mRNA

NCBI chr 4:115,654,968...115,677,979
Ensembl chr 4:117,212,677...117,219,270

G

Wnt family member 1

multiple interactions

ISO

[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of WNT1 mRNA

NCBI chr 7:131,817,558...131,821,605
Ensembl chr 7:131,817,558...131,821,605

G

XK related 8

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of XKR8 mRNA

NCBI chr 5:144,938,061...144,945,195
Ensembl chr 5:150,222,061...150,228,564

G

X-prolyl aminopeptidase 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of XPNPEP2 mRNA

NCBI chr X:132,165,696...132,194,937
Ensembl chr X:132,165,701...132,195,126

G

zeta chain of T cell receptor associated protein kinase 70

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ZAP70 mRNA

NCBI chr 9:46,485,605...46,507,552
Ensembl chr 9:46,485,598...46,509,062

G

zinc finger and BTB domain containing 16

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ZBTB16 mRNA

NCBI chr 8:57,885,886...58,073,507
Ensembl chr 8:57,891,081...58,073,507

G

zinc finger and BTB domain containing 40

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ZBTB40 mRNA

NCBI chr 5:154,499,952...154,569,390
Ensembl chr 5:154,503,128...154,537,863

G

zinc finger CCCH type containing 6

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ZC3H6 mRNA

NCBI chr 3:116,203,466...116,254,186
Ensembl chr 3:136,657,414...136,706,504

G

zinc finger DHHC-type palmitoyltransferase 19

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ZDHHC19 mRNA

NCBI chr11:68,277,847...68,289,110
Ensembl chr11:81,782,903...81,794,008

G

zinc finger homeobox 2

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ZFHX2 mRNA

NCBI chr15:28,533,155...28,565,667
Ensembl chr15:32,503,115...32,535,085

G

zinc finger protein 503

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ZFP503 mRNA

NCBI chr15:2,362,450...2,366,238
Ensembl chr15:2,362,427...2,366,238

G

zinc finger protein 831

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ZFP831 mRNA

NCBI chr 3:163,393,787...163,510,654
Ensembl chr 3:183,811,648...183,927,253

G

ZFP92 zinc finger protein

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ZFP92 mRNA

NCBI chr X:156,268,220...156,293,790
Ensembl chr X:156,268,234...156,294,516

G

zinc finger protein 950

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ZFP950 mRNA

NCBI chr 1:260,248,231...260,265,211

G

zinc finger, matrin type 4

multiple interactions

ISO

[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ZMAT4 mRNA

NCBI chr16:67,969,410...68,361,377
Ensembl chr16:74,671,979...75,063,750

G

zinc finger MYM-type containing 3

decreases expression

ISO

monomethylarsonic acid results in decreased expression of ZMYM3 mRNA

NCBI chr X:70,568,573...70,584,221
Ensembl chr X:70,568,573...70,584,768

phenylarsonic acid

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

glutaminase

decreases expression
decreases activity

ISO

benzenearsonic acid results in decreased expression of GLS protein
benzenearsonic acid results in decreased activity of GLS protein

NCBI chr 9:56,836,584...56,908,861
Ensembl chr 9:56,836,584...56,908,861

G

heme oxygenase 1

increases expression

EXP

benzenearsonic acid results in increased expression of HMOX1 mRNA

NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

angiopoietin 1

decreases expression

ISO

Roxarsone results in decreased expression of ANGPT1 mRNA

NCBI chr 7:75,415,959...75,668,696
Ensembl chr 7:75,418,218...75,668,696

G

chondromodulin

decreases expression

ISO

Roxarsone results in decreased expression of CNMD mRNA

NCBI chr15:55,041,548...55,066,297
Ensembl chr15:61,450,450...61,475,350

G

C-X-C motif chemokine ligand 9

decreases expression

ISO

Roxarsone results in decreased expression of CXCL9 mRNA

NCBI chr14:16,007,166...16,012,077
Ensembl chr14:16,007,204...16,014,299

G

ectonucleotide pyrophosphatase/phosphodiesterase 2

increases secretion

ISO

Roxarsone results in increased secretion of ENPP2 protein

NCBI chr 7:88,092,140...88,214,758
Ensembl chr 7:88,092,140...88,214,957

G

FH2 domain containing 1

decreases expression

ISO

Roxarsone results in decreased expression of INF1 mRNA

NCBI chr 2:169,790,917...169,829,580
Ensembl chr 2:172,089,010...172,125,956

G

hepatocyte growth factor

increases expression

ISO

Roxarsone results in increased expression of HGF mRNA

NCBI chr 4:19,628,902...19,700,467
Ensembl chr 4:19,632,267...19,700,851

G

leptin

decreases expression

ISO

Roxarsone results in decreased expression of LEP mRNA

NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:58,626,523...58,640,661

G

matrix metallopeptidase 9

increases expression

ISO

Roxarsone results in increased expression of MMP9 mRNA; Roxarsone results in increased expression of MMP9 protein

NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442

G

mechanistic target of rapamycin kinase

increases expression
multiple interactions

EXP

Roxarsone results in increased expression of MTOR mRNA
Roxarsone results in increased expression of and results in increased phosphorylation of MTOR protein; Sirolimus inhibits the reaction [Roxarsone results in increased expression of and results in increased phosphorylation of MTOR protein]

NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:164,167,928...164,277,435

G

nitric oxide synthase 3

multiple interactions

ISO

Roxarsone results in increased phosphorylation of and results in increased activity of NOS3 protein

NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:11,686,268...11,706,664

G

platelet and endothelial cell adhesion molecule 1

increases expression
multiple interactions

ISO

Roxarsone results in increased expression of PECAM1 protein
Semaxinib inhibits the reaction [Roxarsone results in increased expression of PECAM1 protein]

NCBI chr10:92,090,263...92,152,002
Ensembl chr10:92,090,235...92,151,839

G

plasminogen

decreases expression

ISO

Roxarsone results in decreased expression of PLG mRNA

NCBI chr 1:50,872,927...50,915,406
Ensembl chr 1:50,872,926...50,917,320

G

ribosomal protein S6 kinase B1

multiple interactions
increases expression

EXP

Roxarsone results in increased expression of and results in increased phosphorylation of RPS6KB1 protein; Sirolimus inhibits the reaction [Roxarsone results in increased expression of and results in increased phosphorylation of RPS6KB1 protein]
Roxarsone results in increased expression of RPS6KB1 mRNA

NCBI chr10:71,817,794...71,865,211
Ensembl chr10:71,815,614...71,865,238

G

vascular endothelial growth factor A

multiple interactions

EXP

Roxarsone results in increased expression of and results in increased secretion of VEGFA protein

NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194

Term paths to the root

Path 1
Term	Annotations
CHEBI ontology	20862
chemical entity	20860
atom	20860
metalloid atom	15683
arsenic atom	15041
arsenic molecular entity	15041
arsenic oxoacid	4267
arsonic acids	664
arsonic acid	664
arsonoyl group	0
organoarsonic acid +	664
Path 2
Term	Annotations
CHEBI ontology	20862
subatomic particle	20860
composite particle	20860
hadron	20860
baryon	20860
nucleon	20860
atomic nucleus	20860
atom	20860
main group element atom	20781
p-block element atom	20781
chalcogen	20491
oxygen atom	20457
oxygen molecular entity	20457
hydroxides	20230
oxoacid	19289
pnictogen oxoacid	15112
arsenic oxoacid	4267
arsonic acids	664
arsonic acid	664
arsonoyl group	0
organoarsonic acid +	664

paths to the root